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4ABSTRACT
The red mold Fusarium, is one of the most prevalent fungal pathogens, infecting 
small-grain cereals in temperate regions of the world. In Scandinavia, F. 
avenaceum, F. culmorum, F. poae, and F. sporotrichioides infections are most 
common, but in recent years, possibly due to climatic changes, F. graminearum 
and F. langsethiae infections have increased, as well. Most Fusarium species are 
capable of producing a variety of mycotoxins, possibly providing an edge over 
competing strains at the site of infection. Mycotoxins can evoke a broad range 
of toxic effects in humans and animals, including neurotoxicity, immunotoxicity, 
reproductive-, and developmental toxicity and carcinogenicity. The most toxic 
fusariatoxins include the tricothecenes, fumonisins and zearalenone. However, less 
studied mycotoxins, as enniatins (Enns) and moniliformin (MON) are frequently 
found in grain products, hence, causing a risk of a daily, low-level exposure of 
human and livestock, the significance of which is still unclear. The aim of this study 
was to provide further insights into the toxicity of Enns and MON, and into the 
mechanism of action of EnnB, monitored at gene expression level. Furthermore, 
the acute oral toxicity and repeated, low-dose, oral toxicity of MON in Sprague-
Dawley rats was assessed, adapting OECD Guidelines 423 and 407.
We report clear toxic outcomes of EnnB in vitro, as it affected cellular energy 
metabolism by reducing ATP levels in cell cultures and cell proliferation, already 
at low concentrations (below 10 μM) in the cell lines Balb 3T3 and HepG2. EnnB 
exposure slightly increased the proportion of early apoptotic cells, as well. Gene 
expression studies revealed alteration of energy metabolism, due to effects on gene 
expression of genes associated with mitochondrial organization and function and 
assembly of complex I of the electron transport chain. 
Moniliformin (MON) did not induce significant toxicity in vitro. However, high 
doses of MON (50 mg/kg b.w.) caused acute toxicity in rats, seen as cardiovascular 
changes and respiratory distress, resulting in death. According to the OECD Globally 
Harmonized System, the toxicity of MON could be classified into category 2, and a 
LD50 cut of value of 25 mg/kg b.w. was determined. Long term, low dose exposure 
affected mainly the innate immunity, by reducing the phagocytic activity of rat 
neutrophils in all tested groups (3 - 15 mg/kg b.w.). Hence, we suggested a LOAEL 
of 3 mg/kg b.w. for MON. The rats of the lowest dose groups (3-6 mg/kg b.w.) 
remained clinically healthy. Two rats of five in the highest dose group (15 mg/
kg b.w.) showed similar signs as in the acute oral toxicity test and died. Excretion 
kinetics revealed that MON is rapidly excreted in urine, in less than 6 h, but only 
1-2% was found in feces. This indicates that the urinary excretion is the main route 
5for elimination and biliary excretion has a minor role. Furthermore, MON is unlikely 
to accumulate in the body, being highly hydrophilic.  
I hope that these results could contribute to risk assessment of moniliformin and 
enniatins in the future, as toxicity studies on moniliformin and enniatin are scarce. 
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ADME Absorption, distribution, metabolism, excretion
ATP Adenosine triphosphate
BEA Beauvericin, mycotoxin
b.w. Body weight
CYP Cytochrome Protein, hemoproteins
DNA Deoxyribonucleic
DON Deoxynivalenol, mycotoxin
EC50 Half maximal effective concentration
ED50 Median effective dose, dose causing effect in 50% of 
population
Enn Enniatin, mycotoxin
ESI Electrospray ionisation
ETC Electron transport chain
FDR False discovery rate
FITC Fluorescein isothiocyanate, fluorochrome
GHS Globally Harmonized System
GI Gastro- intestinal tract
GMP Guanosine monophosphate
GO Gene Ontology, classification term in bioinformatics
GTP Guanosine triphosphate
HILIC Hydrophilic interaction chromatography
Hiv Hydroxyisovaleric acid
HT-2 HT-2 Toxin, mycotoxin 
LD50 Dose lethal to 50% of animals
LOAEL Lowest observed adverse effect level
MAPK/ERK pathway MAP/Extracellular signal–Regulated Kinases, 
intracellular signaling molecules
MON Moniliformin, mycotoxin
MS Mass spectrometry
NMR Nuclear magnetic resonance spectroscopy,
OECD Organisation for Economic Cooperation and 
Development 
p-value Probability value
q-value A p-value adjusted for FDR
Redox reduction–oxidation reaction
RNA Ribonucleic acid
9RT-qPCR Quantitative reverse transcription Polymerase chain 
reaction
T-2 T-2 Toxin  
TCA cycle Tricarboxylic acid cycle
TDI Tolerable daily intake level
UPLC Ultra performance liquid chromatography
Q-Tof Quadrupole-time-of-flight
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1. INTRODUCTION
The kingdom Fungi includes mushrooms, molds, and yeasts and is divided into 
seven phyla. Three phyla produce motile asexual zoospores (with flagella): the 
aquatic fungi Chytridiomycota, the Blastocladiomycota, which are parasites 
of eukaryote, and the anaerobes Neocallimastigomycota, which inhabit the 
digestive systems of herbivores. The remaining four phyla are nonmotile: the 
Glomeromycota, forming mycorrhizae with plant roots, the Ascomycota, which 
are sac fungi including morels, truffles, filamentous fungi, and yeasts, the 
Basidiomycota (most mushrooms), and the microsporidia, which are unicellular 
parasites of animals (Hibbett et al., 2007). Fungi are heterotrophs, using organic 
compounds such as carbohydrates, fats, and proteins as energy sources by secreting 
enzymes to the environment. The cell wall, which is composed of chitin crosslinked 
by glucan and proteins, distinguishes fungal cells from animal cells, which lack a 
cell wall, and plant cells, in which the cell wall is composed of mainly cellulose, 
hemicellulose, pectin, and lignin. 
For thousands of years, fungi have been used by humans as food and in 
food production and preservation via fermentation (beer, wine), bread baking, 
and cheese production. Presently, the use of fungi has widely expanded, mainly 
due to bioengineering techniques, from the large-scale production of some 
chemicals (e.g. citric acid, enzymes), medicine production (antibiotics, statins, 
immunosuppressants), and use in scientific studies, especially yeasts in genetics, 
to new food products such as meat replacements like Quorn, – a mycoprotein 
produced by Fusarium venenatum (Hamlyn, 1997).
Despite a wide range of useful effects, several fungi are pathogens of the kingdoms 
Plantae and Animalia, causing severe economic losses and health hazards. Human 
mycoses range from superficial skin infections such as pityriasis versicolor (caused 
by Malassezia furfur), affecting skin pigmentation, and Candida albicans, mainly 
affecting skin and mucus membranes, to invasive, life-threatening infections, often 
beginning as primary pulmonary infections that disseminate to other organs, e.g. the 
brain, as in coccidioides meningitis, histoplasmosis, aspergillosis, and cryptococcosis 
(Baron, 1996).Fungal plant pathogens infecting agriculturally important plants 
cause severe economic losses globally and also pose a potential health hazard to 
humans and livestock, by producing mycotoxins. Annual losses of up to $ 1.5 billion 
have been estimated to be due to mycotoxin contamination of grain in the United 
States (Schmale and Munkvold, 2009). The most significant plant pathogenic fungal 
species are considered to be Magnaporthe oryzae, infecting rice, Botrytis cinerea 
(gray mold), with a broad host range, Puccinia spp., infecting grain, and Fusarium 
spp., with several subspecies infecting different plants (Dean et al., 2012). In Europe, 
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Fusarium infections are the most prevalent ones in grains, causing plant diseases 
such as crown rot and head blight in cereal grains (wheat, barley and oats), as well 
as, root-, stem-, and ear rot of maize and vascular wilt in several plant species, 
including greenhouse vegetables and fruits (Cerkauskas and Brown, 2001). Several 
fungal species, including most Fusarium species, as well as species of Aspergillus, 
Penicillium, and Clavicpes are capable of producing a variety of secondary 
metabolites, i.e. mycotoxins, possibly providing an edge over competing strains at 
the site of infection (Desjardins, 2006, Jestoi, 2005, Desphande, 2002). Some of 
these mycotoxins have serious consequences for animal productivity and animal 
and human health, increasing the negative economic impacts even further. One of 
the best-known groups of mycotoxins is the hepatotoxic and carcinogenic aflatoxins 
(B1, B2, G1, G2, M1, M2), produced by Aspergillus flavus and A. parasiticus. They 
are common findings in spices, nuts, and grains. Brewery products, cheese, and 
soy sauce are occasionally contaminated with the nephrotoxins ochratoxin (A, B, 
C) and citrínin produced by some Penicillum and Aspergillus species. Claviceps 
purpurea can contaminate grain with ergot alkaloids and cause ergotism, a serious 
condition affecting the central nervous system and causing gangrene in the limbs 
due to vasoconstriction (Desphande, 2002). Patulin, a mycotoxin produced by 
Penicillum expansum, some Aspergillus species, and Paecilomyces in moldy fruits 
and vegetables, is known to affect the immune system (Sorenson, 1986; Desphande, 
2002 ) just to mention a few. 
Following exposure to and entrance of a xenobiotic (e.g. mycotoxin) into the 
body, the elimination or detoxification of the foreign substance often occurs via 
biotransformation reactions. These reactions take place in most tissues (e.g. skin, 
lungs, GI tract), but the main organ involved is the liver. In general, hydrophilic, 
polar chemicals can be excreted more rapidly via urinary or biliary/fecal routes than 
lipophilic chemicals, and hence, biotransformation reactions that modify the toxin 
in order to increase water solubility, thus take place first. These functionalization 
reactions (“ phase I reactions”) include oxidation, reduction, and hydrolysis reactions 
and the addition of polar functional groups (Desphande, 2002). The enzymes 
involved (e.g. cytochrome-P450 monooxygenases, epoxide dehydrolases, alcohol- 
and aldehyde dehydrogenases) are mainly located in the endoplasmic reticulum 
of (liver) cells. In some cases, this is sufficient to remove the foreign substance via 
urine or bile. However, xenobiotics, especially lipophilic substances, often undergo 
even further transformations in order to reduce toxicity or enhance excretion. In 
these conjugation reactions (“Phase II reactions”) enzymes conjugate xenobiotics 
with amino acids (glutamine), glutathione, sulfates, or sugars (glucuronic acid), 
or induce the methylation of amino acids, thiol- and hydroxyl groups to further 
increase water solubility, excretion, and detoxification (Desphande, 2002). For 
some chemical carcinogens and xenobiotics, the biotransformation reactions may 
result in a more toxic end product. For instance, aflatoxin B1 (AFB1), produced 
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by A. flavis and A. parasiticus, can be converted into several different types of 
metabolites, most of which are less toxic. However, oxidation reactions by two 
P450 enzyme family members in liver cells, the CYP1A2 and CYP3A4 in mammals 
(Eaton and Groopman, 1994), and CYP 2A6 in chickens (Diaz et al., 2010), can lead 
to the formation of aflatoxin 8,9-epoxide (AFBO), which is reactive with nucleic 
acids (DNA). Aflatoxin epoxides react with DNA, especially with the base guanine, 
followed by insertion of the molecule between bases in the DNA helix and hence, 
disturbance of the polymerase enzyme function. This leads to the replacement 
or loss of bases of the DNA chain (Tropp, 2011), resulting in mutagenesis and 
carcinogenicity and increasing the risk of liver cancer even at low levels during long-
term exposure (Desphande, 2002, Ch11). AFBO, in turn, can be hydrolyzed to AFB1 
8,9- dihydrodiol  and cause cytotoxic effects in liver cells (Diaz et al., 2010, Eaton 
and Gallanger, 1994). High-level exposure to aflatoxin B1 causes acute toxicity and 
liver damage in many species, including humans, with a 75 mg/kg b.w. dose being 
lethal and having an LD50 value in monkeys of 0.56 mg/kg b.w. (Desphande, 2002). 
Natural toxins, such as Fusarium mycotoxins, are in practice impossible to 
eradicate from food and feed, as molds are always present in growth and storage 
environments. However, the concentrations, occurrence, and carry over to food and 
feed can be reduced by improving agricultural practices and storage facilities and 
through governmental and international legislation, defining maximum permitted 
levels for selected mycotoxins in food and feed. In the European Union (EU), the 
Commission of the European Communities is responsible for risk management 
legislation and policy regarding food additives, substances, and contaminants in 
food, and defines the regulations and legal standards together with the European 
Parliament and member states. The Scientific Committee for Food (SCF) advises 
the Commission regarding the directives (Desphande, 2002). The European Food 
Safety Authority (EFSA) provides scientific risk assessment based on published 
scientific- and epidemiological data. The scientific opinions of EFSA form the basis 
for European policies and legislation. EFSA provides safety assurance for the studied 
xenobiotic or chemical by assessing dose-response relationships and determining 
threshold values for the xenobiotic, such as the NOAEL (no observed adverse effect 
level). NOAEL is divided by a safety factor of normally 100 to yield presumably safe 
levels for consumption: the TDI (tolerable daily intake level) or ADI (acceptable 
daily intake) expressed, for example, as mg/kg body weight (Desphande, 2002, ch 
6). For instance, maximum levels for the Fusarium trichotecene deoxynivalenol 
(DON) are set at 1250 µg/kg in unprocessed cereal grain and 750 µg/kg in flour, 
and the TDI for DON is 1 µg/kg b.w. For the Fusarium mycotoxins T-2/HT-2, the 
TDI has been estimated to be 100 ng/kg b.w (EFSA, CONTAM, 2011). Maximum 
levels for the sum of aflatoxins are set at 5 µg/kg for rice and maize and 2-8 µg/kg 
for different nuts (EC regulation No 1881/2006, EUR-Lex, 2006).
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Climatic and environmental conditions strongly impact on the composition of 
the infective fungal species, as well as their mycotoxin production. Climate change, 
with increases in atmospheric CO2 levels, rising average temperatures and changes in 
humidity and rain quantity, are likely to have an impact on the fungal plant disease 
risk, as fungal species are mostly dependent on humidity for infection. It is difficult 
to predict the outcome of climate change, as the studies are long term and a number 
of changing factors can contribute to the results, e.g. new cultivars, new pesticides, 
changes in planting dates, tillage, changes in vectors or plant pathogen diversity. 
Simulated climate change experiments with elevated temperatures, precipitation, 
or CO2 enrichment treatments are used to reveal trends among plant pathogens or 
so-called “fingerprints of climate change”, and are an ongoing process (Garrett et al., 
2009). Some long- term studies have revealed correlations between plant pathogens 
and climate change. The fear is that plant pathogens will invade new areas or develop 
increased virulence. Hannukkala et al. (2007) compared the incidences of potato late 
blight epidemics, caused by the oomycete or “water mold” Phytophthora infestans 
and climate change during 1933–1962 and 1983–2002 and determined that the 
onset of potato late-blight epidemics in Finland started 2-4 weeks earlier during 
the latter time period and that late-blight had also invaded new areas further north 
(north of latitude 65°N). Another issue that might be linked to climate change is the 
finding that Fusarium graminearum, common in central Europe and previously 
less abundant in Scandinavia, has increasingly been found to infect Scandinavian 
grain since 2000. Also, the new invader F. langsethiae, mainly infecting oats, which 
was first found in Norway in the 1990´s and was also present in Germany, Britain, 
and Denmark, has now spread throughout Scandinavia (Torp and Langseth, 1999, 
Yli-Mattila, 2010). Even though it is extremely difficult to predict the impact of 
climate change on (fungal) plant pathogens, it is clear that new challenges and 
changes will appear, highlighting the need for further studies.  
The science of mycotoxicology includes everything from occurrence data from 
fields, epidemiologic studies, toxicity studies in vivo (acute-, subacute- and chronic) 
and in vitro, to the assessment of the mechanism of action of bioactive molecules 
such as mycotoxins. In epidemiological studies, biomarkers such as metabolites 
and DNA adducts can be scanned from urine, blood, and milk samples in different 
populations. For example, the aflatoxin B1-N7 guanine adduct, The O-demethylated 
aflatoxin B1 metabolite AFP1,  DON, and de-epoxy DON are used as urinary 
biomarkers of exposure and can be used to detect a correlation between the toxic 
outcome and exposure (e.g. hepatocarcinoma vs. aflatoxin exposure) in a population 
(Ross et al.,1992, Eaton and Gallanger, 1994).  
Recently, the tendency in toxicology has shifted from in vivo testing towards 
animal-free assays, not only due to the high costs of animal tests, but also on the 
grounds of public opinion and legislative changes, e.g. the EU ban on animal testing 
in the cosmetic sector from 2013. However, predicting the in vivo relevance of in 
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vitro assays is currently a challenging, if not impossible task. Therefore, in vivo assays 
are still essential and unavoidable in toxicity assessment. In vitro methods provide 
excellent tools in studies on the mechanism of action. A wide range of in vitro cell 
viability tests are available on the market, with several different end points, including 
cell membrane integrity, cell energy (ATP production, mitochondrial effects), 
oxidative stress (glutathione levels, redox status), apoptosis, cell proliferation, and 
protein synthesis. Fluorometric/luminometric methods are worth mentioning, 
since they are rather economical, rapid, and easy to perform. However, mechanistic 
studies often also require the use of extensive research methods, including enzyme 
activity assays and flow cytometric assays etc. Gene expression tests can also be 
a valuable tool to gain further information on the mechanism of toxic insult and 
possible biotransformation reactions. However, they are often costly and laborious 
and require special equipment. There are multiple ways to study gene expression, 
from microarrays producing large amounts of data covering whole genomes, to 
studies on single genes using real-time PCR methods or northern blotting.  
One important issue in in vitro testing is the choice of cells used. The traditionally 
used immortal cell lines have often lost features characteristic of the cells in 
corresponding tissues, and the toxic responses might therefore greatly differ from 
in vivo studies. One solution has been the use of co-cultures of cell lines or cell types, 
or the use of primary cells or tissue slices (e.g. precision-cut liver slices). However, 
these methods are difficult to apply in high-throughput screening. Recently, 2D 
sandwich cultures and 3D cell culture techniques (hanging drop cultures), which 
better simulate tissues and organs, have been established in which cell polarity and 
differentiated functions are better retained (Rimann and Graf-Hauser, 2012,Fraczek 
et al., 2013,Tung et al., 2011). Even 3D high-throughput applications for co-cultured 
primary cell types are nowadays possible, such as 96- well format arrays of spheroids. 
The use of primary cells is not, however, problem free: higher costs, the rapid 
loss of primary cell specific features, high “batch variation”, and the short lifetime 
of cultures (only days) restrict their use. Another problematic issue, especially 
concerning human primary cells, is their availability. One solution to overcome 
this problem in the future would be the use of human induced pluripotent stem 
cells (Sengupta et al., 2014). 
The outcome of gene expression studies in in vitro assays may also be distinct 
from in vivo models, which is good to keep in mind. According to Boess et al., (2003) 
mRNA expression profiles in rodent in vivo studies versus in vitro setups markedly 
differed when comparing precision-cut liver slices, primary hepatocytes, and hepatic 
cell lines with animal settings. Precision-cut liver slices showed expression profiles 
most similar to those in animal studies, while in primary cells the profile differed 
somewhat more, and hepatic cell lines were very divergent from in vivo models. 
Recently, organ-on-chip systems have been developed to mimic organ-specific 
changes on microscale cell culture platforms. In these applications, several fluid 
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chambers and channels are connected to each cell culture well, enabling controlled 
fluid flow and culture conditions. The use of tissue slices, cell lines, primary cells, 
co-cultures of different cell types, and even stem cells is becoming possible in these 
models. One goal is to develop a human on- a- chip model, with cells from several 
organs cultured on one microplatform, where the fluidic system would mimic the 
blood circulation in vivo (Luni et al., 2014), possibly even further reducing the need 
for in vivo studies in the future.
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2. REVIEW OF THE LITERATURE
2.1 The genus Fusarium  
The red mold Fusarium belongs to the sac fungi, Ascomycota, characterized by 
the formation of an ascus – the site of sexual reproduction, nuclear fusion and 
meiosis. Meiosis results in the formation of haploid ascopsores, which germinate 
into new fungi. Both homothallic (self-fertilizing) and heterothallic species 
(two mating types) are represented among the genus. For most strains, sexual 
reproduction is uncommon in nature and rather provides a means for genetic 
recombination and diversity during environmental changes (Brown and Proctor, 
2013). Most Fusarium species reproduce asexually via the mitotic formation of 
conidia (micro and/or macrospores). In some strains, such as F. avenaceum, F. 
poae, and F. culmorum, reproduction is solely asexual (anamorphs) (Kerényi et al., 
2004). Asexual reproduction is a continuous process in favorable environmental 
conditions, and the fusoid-shaped conidia are produced in slimy clusters of 
conidiophores called sporodochia, from which the conidia are spread by splash 
dispersal (Brown and Proctor, 2013). Ascospores are more resistant to extreme 
temperatures and humidity than conidia and are produced during extreme 
environmental conditions. However, for F. graminearum (G. zeae), the airborne 
spread of ascospores is common during the onset of plant disease outbreaks.
Sexual reproduction possibly starts due to pheromone stimulation, causing 
the cytoplasms of the female hyphae (ascogonium) and the male element (micro-, 
macroconidium or hyphae) to fuse. From the ascogonium, the walls of a fruiting 
body, the perithecium, are formed. Inside these walls, dikaryotic ascogonium hyphae 
develop into asci (sac) and haploid ascospores due to nuclear fusion, meiosis, and 
mitotic division. Ascopores are discharged through an opening (ostiole) of the 
perithecium and are efficiently spread into new areas by the wind (Brown and 
Proctor, 2013). Grains are particularly sensitive to Fusarium infections during 
flowering, as the anthers are exposed. The openings for the exchange of oxygen 
and carbon dioxide in leaves, the stomata, also provide an ideal site of initial 
infection. More than 90 species of Fusarium have been characterized, and this 
number is increasing due to better taxonomic tools, including genetics. (Brown 
and Proctor, 2013, Torp and Nirenberg, 2004). To make it even more challenging, 
a group of Fusarium species, the Gibberella fujikuroi species complex, has two 
names: Fusarium for the anamorphic stage and Gibberella for the sexual phase. 
Hence, the telemorph (sexual) phase of Fusarium graminearum is called Gibberella 
zeae and the telemorph of F. verticilloides (formerly F. moniliforme) is Gibberella 
moniliforme. 
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2.2 Fusarium infections in Europe
Common Fusarium species infecting grain in Europe include F. graminearum, 
F. culmorum, F. poae, F. avenaceum, F. sporotrichoides, F. verticilloides, and F. 
tricinctum, but the dominant species in warm and temperate areas of Europe is F. 
graminearum (Yli-Mattila, 2010, Pasquali et al., 2016, Osborne and Stein, 2007). F. 
poae has a preference for cooler climates and is mainly present in northern areas. 
In Scandinavia, F. avenaceum, F. culmorum, F. poae, and F. sporotrichioides 
infections are most common, but in recent years, possibly due to climatic changes, 
F. graminearum and F. langsethiae infections have increased, especially in oats 
(Hietaniemi et al., 2016, Parikka et al., 2014). In Finland, spring cereals appear 
to be more susceptible to Fusarium infections than winter cereals (Hietaniemi et 
al., 2016).
2.3 Fusarium mycotoxicology
Most Fusarium species are capable of producing a variety of mycotoxins, possibly 
providing an edge over competing strains at the site of infection (Bottalico, 
1998, Desjardins, 2006, Jestoi, 2005). Climatic and environmental conditions 
strongly impact on the composition of the infective species and the mycotoxin 
production. Some of these natural toxins have shown acute toxicity (toxicoses) in 
animals and humans, especially the most studied mycotoxins, the trichothecenes, 
zearalenone, and fumonisins. The toxic effects of the mycotoxins are multifold, 
including neurotoxicity, immunotoxicity, reproductive, and developmental 
toxicity and carcinogenicity (Desjardins, 2006). In 2005, the European Union 
set maximum levels for the trichothecene DON (1.2-1.7 mg/kg in unprocessed 
grain) and zearalenone (0.1 mg/kg in unprocessed grain) in cereals and cereal 
products, including maize and maize products (Commission Regulation (EC) No 
856/2005 of 6 June 2005). Recommendations for maximum levels of DON in feed 
(8 mg/kg grain and 12 mg/kg maize) were also established. However, Fusarium 
species produce a number of other less studied secondary metabolites, such as 
moniliformin (MON) and enniatin (Enn), recurrently detected in cereal grain and 
grain-based food and feed in Scandinavian countries (Jestoi, 2005,Uhlig et al., 
2006,Uhlig et al., 2004). Although Enn and MON are common contaminants 
of grain, there is only limited knowledge of the acute and chronic toxicity and 
absorption-, distribution-, metabolism-, and excretion (ADME) and mode of action 
of these two fusariotoxins. There is, hence, a need for further assessments of the 
consequences of their exposure for human and animal health. 
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2.3.1 Fumonisins
Fumonisins are long-chain alcohols, with structural similarity to sphinganine 
(Desjardins, 2006). They are produced by polyketide synthase (PK) enzymes, as 
are many secondary metabolites, pigments, and antibiotics, and other mycotoxins 
such as fusarin and aflatoxin, as well. Polyketide enzymes join carboxylic acids to 
make long carbon chains. Fumonisin synthase is encoded by the FUM1 gene and 
several other genes in the FUM1 gene cluster. The procedure resembles human fatty 
acid production, and both fatty acid synthases and PK contain similar domains: 
the acetyl carrier protein, acyl- or malonyl transferase, and the keto-reductase 
domain. Due to their structural similarity, fumonisins are thought to inhibit the 
enzyme ceramide synthase, catalyzing the reaction from sphinganine fatty acyl-
CoA (acyl-coenzyme A) to ceramide, and toxicity is thought to result from the 
accumulation of sphinganine in cells. (Merrill et al., 1993, Schmelz et al., 1998).
Ceramides are components of sphingomyelin, which makes up the myelin in 
nerve cell axons and is part of the cell membrane lipid bilayer. Hence, fumonisins 
have caused symptoms in the central nervous system, mainly in horses and mules, 
causing a condition known as equine leukoencephalomalachia, which was first 
reported in the US in 1900 and later in south America (1945, 1985-90), China 
(1957 and 1981), South Africa (1972,1976,1981) and Spain (1996). The horses and 
mules suffered from symptoms such as loss of coordination, tremors, paralysis, 
and convulsions. Pathological studies revealed hemorrhaging and liquefaction of 
brain white matter. The condition was ultimately lethal for thousands of horses 
and occurred after feeding with moldy maize that was infected with F. verticilloides 
and contained high levels of fumonisin (Desjardins, 2006). Fumonisins have also 
caused health effects in humans and other animal species, such as pulmonary edema, 
cyanosis, and death in more than 1000 pigs in 1989 in Iowa, US. They have been 
associated with human esophageal cancer in the Transkent area of South Africa 
since 1955, and with an increased number of neural tube defects (spina bifida) along 
the Rio-Grande river area in Mexico in 1990-91 (Desjardins, 2006). 
Fumonisins are not produced by trichothecene producers, but are commonly 
produced among F. verticilloides, F. proliferatum, and the Gibberella fujikuroi 
species complex (Desjardins, 2006). 
2.3.2 Trichothecenes
Many fungal genera, such as Fusarium, Stachybotrys, and Cephaosporium, 
are capable of producing thrichothecenes (McCormick, 2011). Trichothecenes 
are tricyclic sesquiterpenes (C15H24), with a C-12,-13 epoxide ring (Desjardins, 
2006). Sesquiterpenes are composed of 3 isoprene units [C5H8, CH2=C(CH3)-
CH=CH2]. Epoxides have an oxygen molecule between two carbon atoms and 
are generally electrophilic, carcinogenic compounds. All trichothecenes are derived 
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from trichodiene, formed by the enzyme trichodiene synthase from farnesyl 
pyrophosphate. The first Fusarium-produced trichothecene discovered was 
diacetoxyscirpenol, isolated from F. scirpi in 1961. Subsequently, more than 200 
trichothecenes have been isolated (Desjardins, 2006).
Trichothecenes are divided into 4 groups, types A to D, mainly according to 
C-8 substitutions. Type A trichothecenes, (T-2/HT-2 toxins) have a hydroxyl or 
an ester (O-alkyl, e.g. methyl (-O–CH3)) at position C-8, whereas type B (DON, 
nivalenol) has a keto group (C=O). Type C has a C-7-8 epoxide group. Type D 
differs from the others, as it has an additional ring structure between C-4 and C-15 
(McCormick, 2011). Type B trichothecenes are subdivided even further into two 
distinct chemotypes: producers of DON and its acetylated forms 3-ADON and 15-
ADON, and producers of nivalenol and 4-ANIV. Northern F. graminearum strains 
prefer the production of 3-ADON, rather than 15-ADON, in contrast to the southern 
strains (Yli-Mattila, 2010).
Trichothecenes act by inhibiting the protein synthesis of the host, and the 
epoxide ring is needed for protein synthesis inhibition. (Desphande, 2002). 
Trichothecenes bind to the 60S ribosomal unit, hence inhibiting the action of the 
enzyme peptidyltransferase, forming the peptide bond between the amino acids 
at the aminoacyl tRNA site (A site) and the peptidyl tRNA site (P site) on the 
ribosomes. (Rotter, 1996) 
The most important trichothecenes associated with human toxic outbreaks are 
T-2 /HT-2 toxin, nivalenol (NIV), and DON. Trichothecenes are the most studied 
Fusarium mycotoxin group, as they have been associated with serious human and 
animal mycotoxicoses. Cases of a condition called alimentary toxic aleukia were 
reported in Kazakhstan and Russia from 1932 to 1945, causing symptoms such 
as nausea, vomiting, and, diarrhea, a decreased number of blood cells, especially 
leucocytes, skin rashes, and necrotic lesions of the GI tract in patients who had 
consumed overwintered, moldy grains. The grains were later discovered to have 
contained T-2 toxins due to F. sporotrichoides, and F. poae infections. Another 
human toxicosis associated with trichothecenes is “Akakabi-byo”, or “drunken 
bread” syndrome, caused by the mycotoxins nivalenol and DON, in Japan in 
1933. Patients who had consumed red-colored, moldy grain, mainly infected 
with F. graminearum, had symptoms such as nausea, vomiting, and diarrhea, 
as well as, neurological manifestations such as headache, trembling, euphoria, 
and hallucinations (Desjardins, 2006). Toxic outbreaks in animals, due to the 
consumption of feed infected with F. graminearum and containing high levels of 
DON have also been reported, first in the USA in 1928. Swine, fed with moldy barley, 
showed symptoms such as feed refusal, vomiting and weight loss (Desjardins, 2006). 
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Figure 1. Structure of the type B‐trichothescene deoxynivalenol (DON) and type A‐trichothescenes T‐2 and HT‐2, kindly provided by 
Dr. Alexis Nathanail. 
Among Fusarium species, F. graminearum, F. culmorum, F. sporotrichoides, F. poae, and F. langsethiae are 
known trichothecene producers (Desjardins, 2006). F. langsethiae and F. sporotrichoides are common T‐
2/HT‐2 producers in oats, whereas DON and NIV are widely produced by F. graminearum and F. culmorum 
(Bottalico, 1998). In Finnish grain, the DON producer F. culmorum outnumbers F. graminearum infections, 
and F. langsethiae appears to be the main HT‐2/T‐2 producer, especially in oats (Hallikainen et al., 2009). 
  
2.3.3 Zearalenone 
Zearalenone is a resorcyclic acid lactone (cyclic ester), globally found at low levels in maize and grain 
(barley, oats). It is not acutely toxic, but induces estrogenic effects at higher doses (~10 μg/g feed), as it 
binds to estrogen receptors (ERα, ERβ) on several cell types. It causes a condition called estrogenic 
syndrome in farm animals (especially pigs) and rodents, which display symptoms such as enlarged 
mammary glands, atrophy of the ovaries or testes, infertility, and reduced offspring weight. It has also been 
associated with precocious puberty in children in Puerto Rico in the 1980´s. Zearalenone is mainly produced 
by F. graminearum, F. culmorum, and F. crookwellense, and is often coincident with trichothecenes (DON) 
(Desjardins, 2006). 
 
Figure 1. Structure of the type B-trichothescene deoxynivalenol (DON) and type A-trichothescenes T-2 
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Among Fusarium species, F. graminearum, F. culmorum, F. sporotrichoides, F. 
poae, and F. langsethiae are known trichothecene producers (Desjardins, 2006). 
F. langsethiae and F. sporotrichoides are common T-2/HT-2 producers in oats, 
whereas DON and NIV are widely produced by F. graminearum and F. culmorum 
(Bottalico, 1998). In Fin ish grain, the DON producer F. culmoru  o tnumbers 
F. graminearum infections, and F. langsethiae appears to be the main HT-2/T-2 
producer, especially in oats (Hallikainen et al., 2009).
2.3.3 Zearalenone
Zearalenone is a resorcyclic acid lactone (cyclic ester), globally found at low levels in 
maize and grain (barley, oats). It is not acutely toxic, but induces estrogenic effects 
at highe  doses (~10 μg/g feed), as it binds to estrogen receptors (ERα, ERβ) on 
several cell types. It causes a condition called estrogenic syndrome in farm animals 
(especially pigs) and rodents, which display symptoms such as enlarged mammary 
glands, atrophy of the ovaries or testes, infertility, and reduced offspring weight. It 
has also been associated with precocious puberty in children in Puerto Rico in the 
1980´s. Zearalenone is mainly produced by F. graminearum, F. culmorum, and 
F. crookwellense, and is often coincident with trichothecenes (DON) (Desjardins, 
2006).
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2.3.4 Moniliformin
The Fusarium mycotoxin MON, is produced by a number of Fusarium species, 
most belonging to the sexual state (teleomorph) Gibberellae (Schϋtt et al., 1998) 
(Fig 2A). It is a sodium or potassium salt of cyclobutane 1-hydroxycyclobut-3, 
4-dione (Springer et al., 1974)( Fig 2B).
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Figure. 2 A Fusarium avenaceum, producing monilifomin, growing on potato dextrose agar. Figure 2 B Moniliformin, a sodium or 
potassium salt of squeric acid (hydrocyclobutane dione), is formed from two acetate units by oxidation and hydration reactions. 
The figures were kindly provided by Dr. Päivi Parikka (Fig 2A) and Alexis Nathanail (Fig 2B). 
MON has a polar nature and is hence water soluble and weakly acidic (pKa = 1.72) (Steyn et al., 1978). No 
enzymes or genes have been associated with MON synthesis. It is, however, formed from two acetate units 
by oxidation and dehydration reactions (Franck and Breipohl, 1984).  
The exact mechanism of toxicity of MON is still unclear. However, studies on the effects of MON on 
oxidation rates of substrates involved in cell energy metabolism have shown that oxidation of pyruvate and 
ɑ‐ketoglutarate, in particular, but also citrate and iso‐citrate were inhibited in isolated rat mitochondria by 
low concentrations (< 10 μM) of MON (Thiel, 1978, Pirrung and Nauhaus, 1996). Thiel demonstrated that 
MON inhibits the conversion of pyruvate to acetyl‐CoA, and ɑ‐ketoglutarate to succinyl‐CoA, and inhibits 
the tricarboxylic acid (TCA) cycle, and hence the energy metabolism of the cell. Gathercole et al. (1986) 
reported that MON reduced the activity of the enzyme pyruvate dehydrogenase and proposed that 
because of the structural similarity, MON competes with pyruvate for complex formation with thiamin 
pyrophosphate (co‐factor) and hence the binding site of the enzyme. MON could therefore inhibit the 
incorporation of pyruvate into the TCA cycle (Gathercole et al., 1986). This could explain the respiratory 
stress, myocardial effects, and even the mortality of test animals caused by MON (Kriek et al., 1977, Thiel, 
1978, Burka et al., 1982, Gathercole et al., 1986, Nagaraj et al., 1996, Morgan et al., 1999, Engelhardt et al., 
1989, Abbas et al., 1990). MON may also interfere with the polyol pathway, converting glucose to sorbitol 
and sorbitol to fructose, by the inhibition of aldose reductase (Deruiter et al., 1993). Moreover, MON 
inhibits the action of glutathione peroxidase and glutathione reductase, resulting in elevated levels of free 
radicals, which can oxidize unsaturated lipids in biological membranes and cause changes in permeability 
(Chen et al., 1990). 
Fig B 
Figure 2 A Fusarium avenaceum, producing monilifomin, growing on potato dextrose agar. 
Figure 2 B Moniliformin, a sodium or potassium salt of squeric acid (hydrocyclobutane dione), is formed 
from two acetate units by oxidation and hydration reactions. The figures were kindly provided by Dr. Päivi 
Parikka (Fig 2A) and Alexis Nathanail (Fig 2B).
MON has a polar nature and is hence water soluble and weakly acidic (pKa = 1.72) 
(Steyn et al., 1978). No enzymes or genes have been associated with MON synthesis. 
It is, however, formed from two acetate units by oxidation and dehydration reactions 
(Franck and Breipohl, 1984). 
The exact mechanism of toxicity of MON is still unclear. However, studies 
on the effects of MON on oxidation rat s of substrates involved in cell energy 
metabolism have shown that oxidation of pyruvate and ɑ-ketoglutarate, in particular, 
but also citrate and iso-citrate were inhibited in isolated rat mitochondria by low 
co centrations (< 10 μM) of MON (Thiel, 1978, Pirrung and Nauhaus, . i l 
demonstrated that MON inhibits the conversion of pyruvate to acetyl-CoA, and 
ɑ-ketoglutarate to succinyl-CoA, and inhibits the tricarboxylic acid (TCA) cycle, 
and hence the energy metabolism of the cell. Gathercole et al. (1986) reported that 
MON reduced the activity of the enzyme pyruvate dehydrogenase and proposed 
that because of the structural similarity, MON competes with pyruvate for complex 
formation with thiamin pyrophosphate (co-factor) and hence the binding site of the 
enzyme. MON could therefore inhibit the incorporation of pyruvate into the TCA 
cycle (Gathercole et al., 1986). This could explain the respiratory stress, myocardial 
effects, and even the mortality of test animals caused by MON (Kriek et al., 1977, 
Thiel, 1978, Burka et al., 1982, Gathercole et al., 1986, Nagaraj et al., 1996, Morgan 
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et al., 1999, Engelhardt et al., 1989, Abbas et al., 1990). MON may also interfere 
with the polyol pathway, converting glucose to sorbitol and sorbitol to fructose, by 
the inhibition of aldose reductase (Deruiter et al., 1993). Moreover, MON inhibits 
the action of glutathione peroxidase and glutathione reductase, resulting in elevated 
levels of free radicals, which can oxidize unsaturated lipids in biological membranes 
and cause changes in permeability (Chen et al., 1990).
Even though MON has not caused any natural mycotoxicoses in animals or 
humans, it has shown toxicity in experimental animal studies. MON was first 
described in 1973 by Richard Cole, who isolated it from the seeds of corn plants 
suffering from leaf blight caused by the isolate F. moniliforme Sheldon. Cole et al. 
(1973) found this purified water-soluble molecule to be toxic to 1-day-old cockerels 
with an LD50 of 4.0 mg/kg b.w., causing death within 24 h. High doses (40 mg/kg 
b.w.) caused death in only 45 min. In cockerels exposed to ≥ 6.25 mg MON that 
survived for more than 2 hours, hemorrhaging was observed in the proventriculus, 
the small and large intestine, and the skin. However, high doses, that had caused 
death in less than 2 h, did not give rise to any histological changes. Furthermore, 
Cole et al. (1973) reported phytotoxic effects on wheat, corn and tobacco plants, 
with inter-nodal shortening, necrosis, and inter-vein chlorois following single MON 
doses of 200 µg/ml and 2000 µg/ml, respectively, sprayed onto seedlings.
Later studies have confirmed the toxicity of MON in several animal species: 
ducklings, chicks, turkeys, rats, mice, and mink (Engelhardt et al., 1989, Kriek 
et al., 1977b, Morgan et al., 1999). In a 14-day feeding trial by Engelhardt et al. 
(1989), poultry (chicks, turkeys) and ducklings showed clinical signs such as 
dyspnea and cyanosis after receiving feed inoculated with extract of F. moniliforme 
var. subglutinans containing MON. Histological changes could only be seen in 
the heart and liver. Myocardial degeneration (swollen muscle fibers, vacuolation 
of sarcoplasm, lysis of myofibrils) and necrosis were reported, especially in the 
left ventricle and interventricular septum. Vacuolization, swelling, and necrosis 
of hepatocytes were also detected. MON has been found to cause bradycardia in 
broiler chickens in only 15 min post-dosing i.v. with 1 mg/kg b.w. MON, and death 
to 3 of the 7 tested chickens in 50 min (Nagaraj et al., 1996). Similar signs have been 
reported in mice, rats, and mink, and the toxicity appears to be targeted especially 
at the cardiac muscle. Lili et al. (1991) reported that MON reduced the mean arterial 
and left ventricular systolic pressure and increased ventricular diastolic pressure in 
Wistar rats after an i.v. MON dose of 4.5 mg/kg b.w. In the same study, a perfused 
dose of 10 mol/l MON reduced the contractile force of isolated Wistar rat hearts by 
52 % (Lili et al., 1991). Sensitivity to MON, however, varies between animal species. 
The acute oral LD50 for MON in rats and mice is approx. 10 times higher than for 
avian species, as the acute oral LD50 for MON is 41.6 – 50 mg/kg b.w. in rats (Kriek 
et al., 1977b) and 47.6 mg/kg b.w. in mice (Burmeister et al., 1979) compared with 
4.0 mg/kg b.w. in chickens (Cole et al., 1973) and 3.68 mg/kg b.w. in ducklings 
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(Kriek et al., 1977b). The mink seems to be the most sensitive species (LD50 = 2.2-
2.8 mg/kg b.w., i.p. dosing) (Morgan et al., 1999). In vivo studies have confirmed 
that acute MON toxicity is mainly due to effects on cardiac muscle and liver, and 
death is induced by cardiac failure. 
MON has been found at high concentrations (> 400 mg/kg , Poland) in maize 
(Logrieco et al., 1993) and is commonly present at low levels (0.81 and 0.95 mg/kg 
wheat in Finland and Norway, respectively) in grain in Northern Europe (Jestoi, 
2005, Uhlig et al., 2004, Jestoi et al., 2004). It is produced by several Fusarium 
strains, including F. proliferatum, F. nygamai, F. subglutinans, F. thapsinum, F. 
avenaceum, F. tricinctum, and F. fujikuroi (Desjardins, 2006).
2.3.5 Enniatins and beauvericin
Enniatins (Enns) and beauvericin (Bea) belong to a group of cyclic hexadepsipeptides 
that act as ionophores, transporting alkali metal cations (K+, Cs+, Na+, Rb+, Li+, Fr+) 
and small molecules (Ca2+, NH4
+) through biological membranes (Ovchinnikov et 
al., 1974, Hilgenfeld and Saenger, 1982). The core structure is an 18- membered 
ring, with alternating N-methylated amino acids (N-Met AA, in EnnA = isoleucine, 
EnnB = valine, EnnC = leucin, Bea = phenylalanine) and hydroxyisovaleric acids 
(Hiv), joined by ester and amide bonds (Hilgenfeld and Saenger, 1982). The 
macromolecule resembles a disc, where the oxygen atoms of the carbonyl groups 
(of the ester bonds) and the nitrogen atoms (of the amide bonds) interact with the 
cations via ion-dipole bonds (Ovchinnikov et al., 1974, Jestoi, 2005, Hilgenfeld and 
Saenger, 1982). Enns and Bea interact with cations as either 1:1 complexes, where 
1 cation is bound to 1 macromolecule, or by forming “sandwich structures”, where 
2 Enn or Bea molecules surround 1 cation (2:1 complex), making up a lipophilic 
outterior ( due to isopropyl, N-methyl or phenyl groups) and a polar interior, where 
the cation is bound. Even 3:2 complexes have been proposed to exist (Ivanov et 
al., 1973, Ovchinnikov et al., 1974).
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Figure 3. The structure of beauvericin (Bea) and enniatins (Enn).                                                                                                                                                      
The 18‐membered ring structure of Enns and Bea (only ester‐ and amide bonds of N‐Met‐Amino acids and Hydroxyisovaleric acid 
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Figure 3. The structure of beauvericin (Bea) and enniatins (Enn).
The 18-membered ring structure of Enns and Bea (only ester- and amide bonds of N-Met-Amino acids and 
Hydroxyisovaleric acid shown). In the sandwich structure, the cation (K+, Na+) is trapped between two 
Enn or Bea molecules by pole-dipole bonds between the oxygen molecules of ester or amide groups or 
mixtures of them, pointing to the polar interior of the sandwich molecule (Ovchinnikov et al., 1974). The 
figure was kindly provided by Dr. Marika Jestoi.
Biosynthesis of Enns is due to a non-ribosomal multienzyme, enniatin synthetase, 
encoded by the gene esyn1. Nonribosomal peptide synthesis is a multistep 
condensation reaction, and nonribosomal multienzymes contain three types of 
domains: adenylation domains for substrate activation, peptidyl carrier domains, 
and condensation domains, where peptide bonds are formed (Liuzzi et al., 2017). 
The enniatin molecule is made up of three dipeptidols that are condensed, and 
the linear molecule obtains its cyclic form at the cyclization cavity (Hornbogen et 
al., 2002). Bea is produced in a similar way by beauverisin synthetase. The ESYN1 
multienzyme has both a peptide synthase function and an N-methyltransferase 
function, and contains two active sites/modules: the D-hydroxyisovaleric acid 
(D-Hiv) activation module and the L-amino acid (L-valine for EnnB) activation 
module, with an N-methyltransferase domain (Hornbogen et al., 2002). The two 
modules form a dipeptidol from D-Hiv and L-amino acid (L-val for EnnB), which 
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is transferred to a thiol acceptor on the enzyme. Allelic variation in the amino acid-
adenylation domain determines the chemotype (Enn producer versus Enn + Bea 
producer) of the strain, i.e. which amino acid is to be joined (Liuzzi et al., 2017). 
Enns have shown insecticidal effects against the blowfly (Calliphora 
ertyhrocephala), dosed as 1 µl injections into the haemolymph in the dorsum of 
the thorax. containing EnnB, EnnB1, and EnnA killed 28-60% of adult flies. EnnA 
and especially Bea injections were effective against mosquito larvae (Aedes aegypti), 
killing 37% and 86% of the larvae in 48 h, respectively (Grove and Pople, 1980). 
Furthermore, F. avenaceum hyphae and hyphal extracts, containing EnnA and A1 
proved to be lethal to eastern spruce budworms at concentrations of 1% and 0.04% 
W/V in a meridic diet, respectively killing 56% and 24% of the larvae (Strongman 
et al., 1988).
Like MON, Enns have not caused clinical outbreaks in farm animals or humans. 
In in vivo studies, a low level or no toxicity has been observed. In a 28-day subchronic 
feeding study on Wistar rats, with a daily oral dose of 20.91 mg/kg b.w. EnnA, no 
adverse effects were detected (Manyes et al., 2014). The LD50 of fusafungine, an 
antibiotic mixture of Enns, which has been used as oral or nasal inhalation spray 
to treat upper respiratory tract infections, was as high as 350 mg/kg b.w. for mice 
(EFSA Panel on Contaminants in the Food Chain (CONTAM), 2014). Fusafungine is 
an anti-inflammatory compound that inhibits cytokine (IL-10) and tumor necrosis 
factor gamma (TNF-ɣ) production of peripheral blood leukocytes and reduces the 
production of superoxide anion by alveolar macrophages, modulating the acute 
inflammatory reaction (German-Fattal, 2001). In a clinical trial, 41 patients with 
follicular pharyngitis received fusafungine and 40 received a placebo mixture for 7 
days. Fusafungine had an anti-inflammatory effect, as 73% of fusafungine-treated 
patients recovered vs. 51% of the placebo group (Pandraud, 2002). 
As highly lipophilic, Enns have been shown to bioaccumulate in egg yolk (Jestoi 
et al., 2009), and low levels have been recovered from broiler meat, liver, and skin 
in a poultry feeding trial (CODA-CERVA, 2011). In a study by Rodríguez-Carrasco 
(2016), SCID mice intraperitoneally injected with 5 mg/kg b.w. EnnB showed no 
toxic signs or histopathological changes. However, EnnB was recovered from all 
tissues (especially liver and fat) and serum, but not from urine, providing additional 
proof of Enn bioaccumulation. EnnB and Bea also accumulated in human cervical 
cancer xenograft mouse models, supporting the idea that they could act as potential 
anticancer drugs, as previously reported in vitro and in vivo. A combination of 
EnnB and sorafenib (kinase inhibitor) synergistically increased the apoptotic cell 
ratio in cervical cancer cell lines KB-3-1, CaSki, C4-I, and HTB-31 by increasing 
apoptotic cell death via the mitochondrial pathway. Moreover, in vivo (SCID mouse 
xeno-transplantation model) EnnB/sorafenib treatment reduced tumor volume 
and weight and increased the proportion of apoptotic cells to 50 % in the tumor 
tissues. Immunoblotting  analyses (western blot) revealed that EnnB inhibited 
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the ERK signaling pathway, associated with cell proliferation, and the synergistic 
effects were due to changes in p38 MAPK signaling (stress stimuli) (Rodríguez-
Carrasco et al., 2016). Another action of Enns (and the related mycotoxin Bea), 
is the  modulation of the ATPase function (efflux) of two ATP-binding cassette 
(ABC) transporters (ABCB1 and ABCG2) involved in multidrug (e.g. cancer drug 
and antibiotics) resistance. This could be an advantage in drug therapy, as Enns 
may prevent drug efflux out of cells. The ATP-driven efflux pumps in the intestinal 
epithelial cells, form a barrier against drugs by pumping them back to the gut lumen. 
Enn and Bea exposure inhibited the efflux of pheophorbide (PhA) and rhodamin 
123 in lung carcinoma A549 cells and leukemia HL60/Vinc cells, and led to their 
accumulation in the cells by inhibiting ABCB1 and ABCG2 efflux pump function 
(Dornetshuber et al., 2009b). In Candida albicans, Enns also inhibited the efflux 
pump CDR1 associated with fluconazole resistance (Lee et al., 2001). Enns may 
thereby act as chemosensitizers and enhance the absorbance of drugs (e.g. cancer 
drugs and antibiotics) from the intestine.
Despite their low toxicity in vivo, Enns have shown toxicity in vitro in several 
cell lines. The toxic response is thought to be due to the cation-selective sandwich 
formation and transport across biological membranes, resulting in altered ion 
concentrations in the cell (Hilgenfeld and Saenger, 1982, Hornbogen et al., 2002, 
Ovchinnikov et al., 1974). Enns caused lysosomal disruption in Caco-2 cells 
(Ivanova et al., 2012), lysosomal damage in RAW 267.4 macrophages, and cell-
cycle arrest in the G0/G1 phase of the cell cycle (Devreese et al., 2013, Dornetshuber 
et al., 2007, Gammelsrud et al., 2012), and reduced the endocytic capacity of 
macrophages exposed during maturation (Ficheux et al., 2013). Anton Tonshin 
reported mitochondrial dysfunction and a loss of mitochondrial membrane potential 
in isolated rat liver mitochondria, neural cells (Paju), murine insulinoma cells, 
and boar sperm cells, which might affect cellular energy production (Tonshin et 
al., 2010). Enns also altered cell signaling by binding calmodulin and inhibiting 
calmodulin dependent 3,5 - cyclic nucleotide phosphodiesterase, hydrolyzing cyclic-
AMP and cyclic-GMP (the second messengers in cells), and transmitting the signal 
from extracellular molecules, e.g. hormones, glucagon, and adrenaline, into the cell 
(Mereish et al., 1990). MAPK (p38) induction by EnnB, leading to increased cell 
survival due to the stress response, was also reported by Dornetshuber-Fleiss et al. 
(2014). Enns have additionally induced apoptosis in the H4IIE hepatocyte cell line 
by increasing caspase 3/7 activity and causing nuclear fragmentation (Wätjen et 
al., 2009). However, EnnB was reported to cause cell death by necrotic cell death 
in Caco-2 cells, rather than inducing apoptosis (Ivanova et al., 2012). 
Enns are seldom produced among trichothecene-producing strains, but are 
produced by species of the F. oxysporum species complex. Common Enn producers 
include F. avenaceum, F. proliferatum, F. tricinctum, and F. chlamydosporum 
(Desjardins, 2006).   
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3. AIMS OF THE STUDY
Several fungal species infecting agricultural plants, including most Fusarium 
species, produce secondary metabolites, mycotoxins, some of which have serious 
consequences for animal productivity and animal and human health. As mycotoxins 
are in practice impossible to eradicate from food and feed, their toxic effects and 
safe consuming levels are of most importance. Fusarium mycotoxins MON and 
Enns are common findings in Scandinavian grain and as their toxic impact is still 
unclear no TDI or maximum levels have been established.
This dissertation study formed a part of the Akatox project, funded by the 
Academy of Finland. The aims of the study were to provide further insights into 
the toxicity of Enns and MON and into the mechanism of action of EnnB. 
1. In vitro toxicity of both mycotoxins EnnB and MON was studied with an 
emphasis on cellular energy metabolism, cell proliferation, and apoptotic cell 
death in mouse embryo fibroblast Balb 3T3 cells and human hepatocellular 
carcinoma HepG2 cells. 
2. EnnB was further assessed to give an idea of the toxic mechanisms of action, 
monitored at the gene expression level in rat primary hepatocytes.
3. The acute oral toxicity and repeated dose oral toxicity of MON in rats was 
assessed using OECD Guidelines 423 and 407, respectively. The acute oral 
toxicity study was performed to confirm the levels of toxicity (LD50 level), 
clinical signs and target organs of MON and to help in determining the 
exposure levels in the following subacute oral toxicity study. The subacute 
oral toxicity study aimed at defining the possible toxic outcome of longer-term 
exposure and to propose a lowest adverse effect level (LOAEL) for MON. 
Furthermore, in both studies, the excretion kinetics of MON was monitored.
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4. MATERIALS AND METHODS
4.1 In vitro toxicity of EnnB and MON
The mouse fibroblast Balb 3T3 cell line, clone A31 (CCL-163, ATCC, USA), 
sensitive to xenobiotics and the human hepatocellular carcinoma HepG2 cell 
line (HB-8065, ATCC, USA), commonly used in toxicity tests, were chosen for 
the bioassays to monitor the various cytotoxic effects of EnnB and MON, which 
enabled a comparison of the toxic effects between different cell types. Cryopreserved 
rat primary hepatocytes (RTCP 10, Gibco, Life Technologies, USA) were used to 
examine the changes in gene expression profile implicating mechanism of action, 
as primary cells are considered to simulate the in vivo conditions better than cell 
lines, which are transformed and have often lost many of the properties of “parental 
cells”, such as the production of metabolic enzymes.
The effect of EnnB on cell viability was investigated using luminometric bioassays. 
The ToxiLight Bioassay (LT07-217, Lonza, Rockland, USA) measures plasma 
membrane integrity, detecting the leakage of the cytoplasmic enzyme adenylate 
kinase (AK) through the cell membrane into the culture medium. AK phosphorylates 
ADP to form ATP, which is measured using the bioluminescent firefly luciferase 
reaction. The ViaLight Plus bioassay (LT37-620, Lonza, Rockland, USA) was used to 
study the effects of the mycotoxins on energy metabolism (cellular ATP levels). The 
ATP content of lysed cells is measured using the firefly enzyme luciferase, cellular 
ATP, and added luciferin to produce light. The emitted light intensity is linearly 
related to the ATP content of the cell culture. The luminescence was measured 
using a Victor3 Multilabel Plate Reader 1420 (Perkin Elmer, Belgium). The cells 
were grown in standard conditions (37 °C, 5% CO2, humid atmosphere) on white, 
flat, clear-bottomed, 96-well plates (Viewplate-96TC, Perkin-Elmer) at a density 
of 10 000 cells/well and were exposed for 24 h to different toxin concentrations in 
growth medium (100 µl/well) ranging from 1.5 μM to 100 μM EnnB or 250 µM to 
1200 µM MON. Both experiments were performed according to the manufacturer´s 
protocols using the same cell samples. The data were collected from a minimum 
of three independent experiments, with 3 to 5 replicates.
The cytotoxic effects of EnnB and MON on cell proliferation were investigated 
by monitoring changes in the levels of DNA synthesis, using a chemiluminescent 
cell proliferation ELISA immunoassay (Ref 1166915001, Roche Diagnostics 
GmbH, Mannheim, Germany). This assay measures the quantity of BrdU 
(bromodeoxyuridine)-labeled DNA precursors, incorporated into newly synthesized 
DNA instead of thymidine by dividing cells. The amount of synthesized DNA is 
detected by a quantitative cellular enzyme immunoassay, using monoclonal 
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antibodies against BrdU. The chemiluminescence (rlu/sec), produced by luminol, 
correlates with the level of DNA synthesis in the cell. Balb 3T3 cells, grown in 
standard conditions and plated on black, flat, 96-well plates (CellBIND, Corning, 
USA) at a density of 3000 cells/well, were exposed to 3-12 µM EnnB or 100 -1000 
µM MON in growth medium for 24 h . HepG2 cells were only exposed to 1-10µM 
EnnB for 24 h in standard conditions. The test was performed according to the 
manufacturer´s instructions.
The last endpoint, apoptotic cell death, was studied by means of fluorescent 
staining of cells and flow cytometric analyses. In the early stages of apoptosis, 
cells translocate phosphatidylserine (PS) from the inner surface of the plasma 
membrane to the cell surface. PS on the outside of the plasma membrane was 
detected by staining cells with FITC- labeled Annexin V protein (Annexin V-FITC 
/ PI double-staining kit, K101-100, Biovision). The kit includes Annexin V-FITC 
for detecting apoptotic cells and propidium iodide (PI), for staining the nuclei of 
necrotic cells. Intact cells remain unstained. Balb 3T3 cells, were cultured in standard 
conditions on 6-well plates (CatNo140685, Nunc), 450 000 cells/well, and were 
exposed to 11 µM, 22 µM and 45 µM EnnB or 800 µM MON in culture medium 
for 24 h. As a positive control, camptothecin concentrations of 10 μM and 20 µM 
were used, and the growth medium served as a negative control. The proportion of 
pre-apoptotic cells, necrotic cells and intact cells was measured by flow cytometric 
analysis using a BD FACSAria II flow cytometer (Becton, Dickinson and Company) 
and BD FACSDiva software.
Gene expression studies
Rat primary hepatocytes (RTCP 10, Gibco, Life Technologies, USA) were maintained 
and cultured according to the manufacturer´s instructions using optimized thawing 
medium (CHRM, APScineces, USA), plating medium (CHPM, APScineces, USA) 
and maintenance medium (William’s E medium, without phenol red, Cat A1217601, 
supplemented with 4% cocktail B, Cat A13448, Gibco, Life Technologies, UK). The 
cells were plated at a density of 2000 viable cells/well on collagen-coated 6-well 
plates (Thermo Scientific, NY USA) and cultured (12 h ) in standard conditions in 
order to attach to the collagen surface. The cells were then exposed for 1 and 4 h in 
standard conditions to 0 μM, 1 μM, 10 μM or 20 μM EnnB in maintenance medium. 
The doses represented a negative control, a low toxin level, the EC50, and a high 
level of toxin. RNA was isolated using the RNeasy Plus Mini Kit (Cat. No. 74134, 
Qiagen). Genome-wide expression analysis of the exposed rat primary hepatocyte 
samples was carried out by the Functional Genomics Unit at the University of 
Helsinki in April 2013, using rat total genome RaGene 2.0 ST expression arrays 
(Ref 520784, Affymetrix, USA) and the Affymetrix standard protocol. The labeling 
and hybridization were carried out according to the manufacturer’s instructions 
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with minor modifications, using the Ambion WT Expression Kit for Affymetrix 
GeneChip Whole Transcript Expression Arrays (Part Number 4425209 Rev. C 
09/2009, Applied Biosystems). The probe-group intensity data were collected 
using a GeneChip® Scanner (Affymetrix, USA). The data were collected from 4 
independent experiments. The Gene Ontology (GO) enrichment analysis of the 
transcriptome was performed using Blast2GO software (Conesa et al., 2005) and 
the hierarchical cluster analysis (Euclidean distance) was performed using the 
TMeV Multiple Experiment Viewer 4.9.0 software (Saeed et al., 2003).
Seven genes were chosen on the basis of the microarray experiment for further 
expression analysis. The results of selected genes were confirmed by RT-qPCR, using 
KiCqStart® SYBR Green qPCR reagents and BioRad CFX96 equipment (Sigma-
Aldrich). The rat SDHA gene served as a reference gene. The rat primary cells were 
treated as in the array experiments and the experiment was repeated twice. Three 
technical repeats were used for each gene. The relative quantification was analyzed 
by the Pfaffl method (Bio-rad, 2006). The experiment was performed twice.
4.2 In vivo toxicity of MON
A single-dose, 14-days acute oral toxicity study was carried out according to 
OECD Guideline 423, with some minor modifications. This method enables the 
classification of test compounds into different categories of toxicity and estimation 
of the LD50 for the toxins (Fig. 2 in article II). Male Sprague-Dawley rats aged 
9-10 weeks were used in this study. A low dose of 5 mg/kg b.w. and a high dose 
of 50 mg/kg b.w. were administered to the rats by gavage, followed by clinical 
observations, collection of urine and fecal samples, gross necropsy and histological 
examination of tissue samples, and mass spectrometric excretion studies of the 
urine and fecal samples, analyzed using a Waters ACQUITY UPLC™ (Milford, 
MA, USA) system coupled to a Micromass Q-Tof Premier™ (Waters, Manchester, 
UK) and HILIC column.
Subacute toxicity studies on MON were performed by adapting OECD Guideline 
407. Contradictorily to the OECD Guideline, no female rats were used to minimize 
the amount of animals. In this experiment, 5 dose groups (3, 6, 9, 12, and 15 mg/kg 
b.w.), each consisting of 5 Sprague-Dawley rats, were exposed to MON by gavage 
for 28 days. In addition, a negative control group and two satellite groups (dosed 
with 12 and 15 mg/kg b.w. MON) were included. The two satellite groups were kept 
alive for an additional 14 days to detect possible delayed toxic effects and to follow 
up recovery. Clinical observations were carried out twice daily and urine and fecal 
samples were collected at set time points following mass spectrometric excretion 
studies. Blood samples were collected once a week and prior to euthanasia. Analysis 
of blood parameters (red blood cell counts, white blood cell counts, haemoglobin, 
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haematocrit, platelet counts) were performed at the University of Helsinki, Faculty 
of Veterinary Medicine, Department of Equine and Small Animal Medicine. In 
addition, a luminol-amplified chemiluminescence (CL) assay was performed to 
study neutrophil activity. Gross necropsy and histological examination of tissue 
samples were performed for all test animals. 
All experiments were conducted under a permit from the National Animal 
Experiment Board of Finland. 
Table 1. Studies, compounds and models. 
Compounds Study Model of study Article
EnnB, isolated from F. orthoceras var 
ennatum, A.G. Scientific, INC, USA. 
The purity was demonstrated to be ≥ 
90-99% (HPLC analysis).
Bioassays Balb 3T3, clone A31 
(CCL-163, ATCC, USA)
Human hepatocellular 
carcinoma cell line HepG2
(HB-8065, ATCC, USA)
I
EnnB, isolated from Gnomonia 
errabunda,
Sigma-Aldrich, USA. The purity was 
demonstrated to be ≥ 95% (HPLC 
analysis).
Gene 
expression 
studies
Cryopreserved rat primary 
hepatocytes 
(RTCP10, Gibco, Life 
Technologies, USA)
I
Synthetic potassium salt of MON
Provided by Dr. Ilkka Kilpeläinen 
and Dr. Pirkko Karhunen, Dept of 
Chemistry, University of Helsinki.
Acute oral 
toxicity 
study
Sprague-Dawley rat 
(male)
Harlan Laboratories Inc.
II
Synthetic potassium salt of MON
Provided by Sigma-Aldrich, Bangalore, 
India
Repeated-
dose 28-
day study
Sprague-Dawley rat 
(male)
Harlan Laboratories Inc.
III
Moniliformin sodium salt from 
Fusarium proliferatum, M5269, Sigma- 
Aldrich, USA. Purity was studied by 
HPLC analysis.
Bioassays Balb 3T3, clone A31 
(CCL-163, ATCC, USA)
Human hepatocellular 
carcinoma cell line HepG2
(HB-8065, ATCC, USA)
unpublished
data
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Table 2. Methods and assays 
In vitro Methods Assay Article
Cell membrane integrity
Adenylate kinase (AK) 
leakage from cells
ToxiLight assay
LT07-217, Lonza, Rockland, USA I
Cytotoxicity 
ATP production of cell lysates
ViaLight assay
LT07-221, Lonza, Rockland, USA I
Cell proliferation
BrdU incorporation into DNA
BrdU Elisa, chemiluminescent,
Ref 1166915001, Roche Diagnostics GmbH, Mannheim, 
Germany
I
Apoptosis
Flowcytometer measurements
Annexin V-FITC/PI double staining kit
Cat # K101-25, Biovision I
Gene expression studies
RNA isolation
RNeasy Plus Minikit, 
Cat. No. 74134, QIAGEN
QIAshredder columns
Cat. No. 79654, QIAGEN.
I
Gene expression studies
Microarray method: 
Rat total genome RaGene 2.0 array 
Ref 520784, Affymetrix, USA
Ambion WT Expression Kit for Affymetrix GeneChip 
Whole Transcript Expression Arrays 
Part Number 4425209, Rev. C 09/2009, Applied 
Biosystems
I
RT-qPCR method
RNA isolation
cDNA synthesis
RNeasy plus mini kit
Cat. No. 74134,Quiagen
ReadyScriptTM cDNA Synthesis Mix 
Sigma-Aldrich
Predesigned KiCqStart SYBR green primers, Sigma-
Aldrich
KiCqStart® SYBR Green qPCR Ready MIX for BioRad 
CFX 
Sigma-Aldrich, KCQS00 
I
In vivo methods
Sprague-Dawley rat housing
Acute oral toxicity study 
Repeated-dose, 28-day, oral 
toxicity study, 
Necropsy and histopathology
 
Excretion 
Immunotoxicity
OECD Guideline 423
OECD Guideline 407
Evaluation of macroscopic changes
Light microscopy of haematoxylin and eosin stained, 
paraffin embedded tissue  samples.
UPLC-Q-Tof-MS analysis of moniliformin in urine and 
fecal samples
Neutrophil activity chemiluminescence assay 
III
II, III
II
III
II, III
II, III
III
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5. RESULTS
5.1 In vitro toxicity of EnnB and MON
5.1.1 Light microscopy
Light microscopy of the cell lines Balb 3T3 and HepG2 cells, exposed to 
concentrations of EnnB ranging from 3 µM to 60 µM, did not show clear 
morphological changes typical of cell death - neither apoptosis nor necrosis. 
Instead, the cells remained intact, and exposures to ≥ 10 µM EnnB lowered the 
cell density and visibly increased cell size, compared to negative control cells. 
Furthermore, mitotic cells (with rounded morphology) were less abundant in the 
EnnB exposed cell culture than in the negative control, also indicating a decrease 
in cell proliferation (Fig4 A and B).
Light microscopic studies also revealed contradictory effects of EnnB on rat 
primary hepatocytes compared to studies conducted on the cell lines (Balb 3T3 
and HepG2). Even short-term and low-level (4 h, 10 µM) exposure of rat primary 
hepatocytes to EnnB, resulted in rounded rat primary cells with a granulated cell 
morphology and detachment of cells from the collagen-coated culture plates, ending 
in the release of cell contents in a necrotic manner (Fig. 4. C and D), indicating a 
clearly different outcome depending on the cell type.
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Figure 4.Light microscopic images of untreated mouse Balb 3T3 cells (A) and cells exposed to 11 µM EnnB for 24 h (B). The exposed 
cells remained intact, but stopped proliferating, giving rise to a less dense cell culture compared to the negative control. Untreated 
rat primary hepatocytes before (C) and after exposure to 10 µM EnnB for 210 min (D). Primary hepatocytes detached from the 
collagen‐coated culture plate. 20x objective, EVOS® XL Imaging System, Thermo Fisher Scientific. 
 
5.1.2 Cell viability: cell membrane integrity, cell energy production, and cell proliferation 
In Balb 3T3 cells, no leakage of the cell membranes could be detected post exposure to EnnB or MON, 
tested by measuring AK levels in the growth medium (Fig. 5A and B). Cell viability was further confirmed by 
Figure 4.Light microscopic images of untreated mouse Balb 3T3 cells (A) and cells exposed to 11 µM EnnB 
for 24 h (B). The exposed cells remained intact, but stopped proliferating, giving rise to a less dense cell 
ulture compared to the negative control. Untreated rat primary hepatocytes before (C) and after exposure 
to 10 µM EnnB for 210 min (D). Primary hepatocytes detached from the collagen-coated culture plate. 20x 
objective, EVOS® XL Imaging System, Thermo Fisher Scientific.
5.1.2 Cell viability: cell membrane integrity, cell energy production, and 
cell prolif ration
In Balb 3T3 cells, no leakage of the cell membranes could be detected post exposure 
to EnnB or MON, tested by measuring AK levels in the growth medium (Fig. 5A and 
B). Cell viability was further confirmed by flow cytometric studies, which indicated 
that most Balb 3T3 cells remained intact after a 24-h exposure to 11 µM, 22 µM, 
and 45 µM EnnB, as the ratio of intact cells to damaged cells was comparable to 
that of unexposed control cells (86 % intact cells in negative control versus 96.6 
% at the 11 µM EnnB exposure level and 84.3 % at 45 µM EnnB).
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flow cytometric studies, which indicated that most Balb 3T3 cells remained intact after a 24‐h exposure to 
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Figure 5. Plasma membrane integrity of Balb 3T3 cells, measured by adenylate kinase (AK) leakage from the cell cytoplasm, was not 
affected by the tested concentrations of EnnB (Fig 5A) or MON (Fig 5 B) after a 24‐h exposure period. Ethanol was used as a positive 
control for cellular damage and unexposed cells as a negative control. A lysed cell sample represented the maximal measureable 
effect. Relative light units (RLU) are directly proportional to the amount of AK in growth media. 
However, a clear, dose‐dependent reduction in ATP production and cell proliferation was seen after a 24‐h 
EnnB exposure in both cell lines (Balb 3T3 and HepG2), resulting in a steep decline in ATP levels (Fig 6A) and 
in de novo DNA synthesis at low concentrations (Fig 7A). In ATP production, the ED50 value for EnnB was 
8.41 μM for Balb 3T3 cells and 2.87 μM for HepG2 cells. In DNA synthesis, the corresponding ED50 values 
were 4.24 μM (Balb 3T3 cells) and 0.50 µM (HepG2 cells). HepG2 cells proved to be more sensitive to EnnB 
exposure than Balb 3T3 cells, although Balb 3T3 cells are generally considered a very sensitive cell line to 
xenobiotic insults. However, the toxic impact in both cell lines lay within the same concentration range.  
MON exposure, on the other hand, did not appear to have any effects on the cell membrane integrity (Fig 
5B) or ATP production in the cell lines (Fig 6B), although very high doses of MON (ED50 = 800 µM) had an 
inhibitory effect on cell proliferation (Fig 7B).  
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Figure 6. A 24‐h EnnB exposure resulted in a drop in ATP production in Balb 3T3 cells and HepG2 cells, with ED50 values of 8.4 ± 
0.76 µM and 2.9 ± 0.77 µM, respectively (Fig 6A). MON exposure did not affect cell energy production in either of the cell lines     
(Fig 6B). Ethanol was used as a positive control and unexposed cells as a negative control. A lysed cell sample represent the 
maximal measureable effect. Relative light units (RLU) are directly proportional to the amount of ATP in cell culture. 
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flow cytometric studies, which indicated that most Balb 3T3 cells remained intact after a 24‐h exposure to 
11 µM, 22 µM, and 45 µM EnnB, as the ratio of intact cells to damaged cells was comparable to that of 
unexposed control cells (86 % intact cells in negative control versus 96.6 % at the 11 µM EnnB exposure 
level and 84.3 % at 45 µM EnnB). 
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Figure 5. Plasma membrane integrity of Balb 3T3 cells, measured by adenylate kinase (AK) leakage from the cell cytoplasm, was not 
affected by the tested concentrations of EnnB (Fig 5A) or MON (Fig 5 B) after a 24‐h exposure period. Ethanol was used as a positive 
control for cellular damage and unexposed cells as a negative control. A lysed cell sample represented the maximal measureable 
effect. Relative light units (RLU) are directly proportional to the amount of AK in growth media. 
However, a clear, dose‐dependent reduction in ATP production and cell proliferation was seen after a 24‐h 
EnnB exposure in both cell lines (Balb 3T3 and HepG2), resulting in a steep decline in ATP levels (Fig 6A) and 
in de novo DNA synthesis at low concentrations (Fig 7A). In ATP production, the ED50 value for EnnB was 
8.41 μM for Balb 3T3 cells and 2.87 μM for HepG2 cells. In DNA synthesis, the corresponding ED50 values 
were 4.24 μM (Balb 3T3 cells) and 0.50 µM (HepG2 cells). HepG2 cells proved to be more sensitive to EnnB 
exposure than Balb 3T3 cells, although Balb 3T3 cells are generally considered a very sensitive cell line to 
xenobiotic insults. However, the toxic impact in both cell lines lay within the same concentration range.  
MON exposure, on the other hand, did not appear to have any effects on the cell membrane integrity (Fig 
5B) or ATP production in the cell lines (Fig 6B), although very high doses of MON (ED50 = 800 µM) had an 
inhibitory effect on cell proliferation (Fig 7B).  
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(Fig 6B). Ethanol was used as a positive control and unexposed cells as a negative control. A lysed cell sample represent the 
maximal measureable effect. Relative light units (RLU) are directly proportional to the amount of ATP in cell culture. 
 
Figure 5. Plasma membrane integrity of Balb 3T3 cells, measured by adenylate kinase (AK) leakage from 
the cell cytoplasm, was not affected by the tested concentrations of EnnB (Fig 5A) or MON (Fig 5 B) after 
a 24-h exposure period. Ethanol was used as a positive control for cellular damage and unexposed cells 
as a negative control. A lysed cell sample represented the maximal measureable effect. Relative light units 
(RLU) are directly proportional to the amount of AK in growth media.
However, a clear, dose-dependent reduction in ATP production and cell proliferation 
was seen after a 24-h EnnB exposure in both cell lines (Balb 3T3 and HepG2), 
resulting in a steep decline in ATP levels (Fig 6A) and in de novo DNA synthesis 
at low concentrations (Fig 7A). In ATP production, the ED50 value for EnnB was 
8.41 μM for Balb 3T3 cells and 2.87 μM for HepG2 cells. In DNA synthesis, the 
corresponding ED50 values were 4.24 μM (Balb 3T3 cells) and 0.50 µM (HepG2 
cells). HepG2 cells proved to be more sensitive to EnnB exposure than Balb 3T3 
cells, although Balb 3T3 cells are generally considered a very sensitive cell line to 
xenobiotic insults. However, the toxic impact in both cell lines lay within the same 
concentration range. 
MON exposure, on the other hand, did not appear to have any effects on the cell 
membrane integrity (Fig 5B) or ATP production in the cell lines (Fig 6B), although 
very high doses of MON (ED50 = 800 µM) had an inhibitory effect on cell proliferation 
(Fig 7B). 
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flow cytometric studies, which indicated that most Balb 3T3 cells remained intact after a 24‐h exposure to 
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unexposed control cells (86 % intact cells in negative control versus 96.6 % at the 11 µM EnnB exposure 
level and 84.3 % at 45 µM EnnB). 
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EnnB exposure in both cell lines (Balb 3T3 and HepG2), resulting in a steep decline in ATP levels (Fig 6A) and 
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exposure than Balb 3T3 cells, although Balb 3T3 cells are generally considered a very sensitive cell line to 
xenobiotic insults. However, the toxic impact in both cell lines lay within the same concentration range.  
MON exposure, on the other hand, did not appear to have any effects on the cell membrane integrity (Fig 
5B) or ATP production in the cell lines (Fig 6B), although very high doses of MON (ED50 = 800 µM) had an 
inhibitory effect on cell proliferation (Fig 7B).  
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Figure 6. A 24‐h EnnB exposure resulted in a drop in ATP production in Balb 3T3 cells and HepG2 cells, with ED50 values of 8.4 ± 
0.76 µM and 2.9 ± 0.77 µM, respectively (Fig 6A). MON exposure did not affect cell energy production in either of the cell lines     
(Fig 6B). Ethanol was used as a positive control and unexposed cells as a negative control. A lysed cell sample represent the 
maximal measureable effect. Relative light units (RLU) are directly proportional to the amount of ATP in cell culture. 
 
Figure 6. A 24-h EnnB exposure resulted in a drop in ATP production in Balb 3T3 cells and HepG2 cells, 
with ED50 values of 8.4 ± 0.76 µM and 2.9 ± 0.77 µM, respectively (Fig 6A). MON exposure did not affect 
c ll energy pro uction in ei her of th  cell lines     (Fig 6B). Ethan l was us d as a positive control and 
unexposed cells as a negative control. A lysed cell sample represent the maximal measureable effect. 
Relative light units (RLU) are directly proportional to the amount of ATP in cell culture.
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7. The effect of a 24‐h EnnB exposure can be seen as a steep decline in de novo DNA synthesis, measured as BrdU incorporation 
into DNA. Relative light units (RLU) are directly proportional to the amount of BrdU incorporated in cell DNA (cells in S‐phase).     
ED50 values for EnnB of 4.2 ± 0.06 µM in Balb 3T3 cells and 0.5 ± 0.09 µM in HepG2 cells could be determined (Fig 7 A). MON 
reduced cell proliferation, but at very high concentrations (> 500 µM), with an ED50 value of 800 µM in Balb 3T3 cells (Fig 7 B). 
Deoxynivalenol (DON) served as a positive control and untreated cells as a negative control. 
 
 
5.1.3 Apoptosis 
The ability of EnnB to induce apoptotic changes in Balb 3T3 cells was investigated with Annexin V‐FITC/PI 
staining of early‐ and late apoptotic, as well as, necrotic Balb 3T3 cell populations followed by flow 
cytometric measurements (Fig. 8). A 24‐h EnnB exposure moderately increased the proportion of early 
apoptotic cells in a dose‐dependent manner from 0.3% (negative control) to 1.25% (11 µM), 2.5% (22 µM), 
and 4.4% (45 µM), respectively (Fig. 9). The positive control, camptothecin, had a similar pro‐apoptotic 
effect, increasing the early apoptotic cell population to 1.85% (10 μM) and 3.0% (20 µM). A rising trend 
could also be seen in the late apoptotic/necrotic cell population, although it was not statistically significant. 
A 48‐h EnnB exposure gave rise to similar findings, with a statistically significant increase in the early 
apoptotic cell population from 0.0% to 3.6% at the highest EnnB dose of 45 µM (data not shown). EnnB 
apparently had an apoptotic effect on Balb 3T3 cells, comparable to the positive control camptothesin. On 
the other hand, the majority of cells were unaffected (96.6% for 11 µM, 91% for 22 µM, and 84.3% for 45 
µM EnnB), at levels comparable to the unexposed control cells (86%), suggesting that apoptosis is not the 
main event in EnnB‐induced toxicity in the tested concentrations. Furthermore, gene expression studies 
(section 5.2) confirmed that genes central to apoptotic events (e.g. caspase‐3, ‐8, ‐9, Tradd, Bid, Apaf‐1, 
Aifm) were down regulated or unchanged in EnnB treated cells.    
MON did not induce apoptosis in the tested cells, even at high exposure levels (600 µM and 1 mM), as the 
proportion of the early apoptotic cell population after 24 h of treatment (0.7 % and 0.4%, respectively) was 
close to the negative control (0.3%).  
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Figure 7. The effect of a 24-h EnnB exposure can be seen as a steep decline in de novo DNA synthesis, 
measured as BrdU incorporation into DNA. Relative light units (RLU) are directly proportional to the amount 
of BrdU incorporated in cell DNA (cells in S-phase).     ED50 values for EnnB of 4.2 ± 0.06 µM in Balb 3T3 
cells and 0.5 ± 0.09 µM in HepG2 cells could be determined (Fig 7 A). MON red ced cell proliferation, 
but at very high concentrations (> 500 µM), with an ED50 value of 800 µM in Balb 3T3 cells (Fig 7 B). 
Deoxynivalenol (DON) served as a positive control and untreated cells as a negative control.
5.1.3 Apoptosis
The ability of EnnB to induce apoptotic changes in Balb 3T3 cells wa  investigated 
with Annexin V-FITC/PI staining of early- and late apoptotic, as well as, necrotic 
Balb 3T3 cell populations followed by flow cytometric measurements (Fig. 8). A 
24-h EnnB exposure moderately increased the proportion of early apoptotic cells in 
a dose-dependent manner from 0.3% (negative control) to 1.25% (11 µM), 2.5% (22 
µM), and 4.4% (45 µM), respectively (Fig. 9). The positive control, camptothecin, 
had a similar pro-apoptotic effect, increasing the early apoptotic cell population 
to 1.85% (10 μM) and 3.0% (20 µM). A rising trend could also be seen in the late 
apoptotic/necrotic cell population, although it was not statistically significant. A 
48-h EnnB exposure gave rise to similar findings, with a statistically significant 
increase in the early apoptotic cell population from 0.0% to 3.6% at the highest 
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EnnB dose of 45 µM (data not shown). EnnB apparently had an apoptotic effect 
on Balb 3T3 cells, comparable to the positive control camptothesin. On the other 
hand, the majority of cells were unaffected (96.6% for 11 µM, 91% for 22 µM, 
and 84.3% for 45 µM EnnB), at levels comparable to the unexposed control cells 
(86%), suggesting that apoptosis is not the main event in EnnB-induced toxicity 
in the tested concentrations. Furthermore, gene expression studies (section 5.2) 
confirmed that genes central to apoptotic events (e.g. caspase-3, -8, -9, Tradd, Bid, 
Apaf-1, Aifm) were down regulated or unchanged in EnnB treated cells.   
MON did not induce apoptosis in the tested cells, even at high exposure levels 
(600 µM and 1 mM), as the proportion of the early apoptotic cell population after 
24 h of treatment (0.7 % and 0.4%, respectively) was close to the negative control 
(0.3%). 
35 
 
                                                                
 
Figure 8. The Annexin‐V FITC/PI staining kit (Biovision) stains the phosphatidylserine (PS) molecules on the outside of the plasma 
membrane of apoptotic cells green (Annexin V‐FITC) and propidium iodide (PI) stains the nucleus of necrotic cells red. Intact cells 
remain unstained. In figure 8, apoptotic (green) (Fig 8B) and necrotic (red) (Fig 8A) Balb 3T3 cells are presented. The cells were 
exposed to 22 µM EnnB for 24 h and stained with the Annexin V‐FITC/PI double stain kit. The proportion of apoptotic vs. necrotic 
cells was determined by flow cytometric measurements.   
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Figure 9. Proportion on apoptotic cells in Balb 3T3 cell cultures post a 24 h exposure.  Exposure to enniatin B (EnnB) had a tendency 
to increase the early apoptotic cell populations compared to the negative control cells. EnnB caused pro‐apoptotic changes at the 
same dose and of the same level as the positive control camptothecin. MON did not affect the apoptotic cell population compared 
to the negative control cells. The doses used in this test were determined from previous in vitro toxicity tests.  
  
5.2 Gene expression studies on EnnB 
To give an insight to the mode of action of EnnB, a whole genome gene expression study (Affymetrix gene 
chip array) on rat primary hepatocytes was conducted. As MON induced cytotoxic effects in vitro only at 
extremely high concentrations (in DNA synthesis, ED50 = 800 µM), gene expression studies with MON were 
not carried out. 
5.2.1 Microarray data 
Figure 8. The Annexin-V FITC/PI staining kit (Biovision) stains the phosphatidylserine (PS) molecules on 
the outside of the plasma membrane of apoptotic cells green (Annexin V-FITC) and propidium iodide (PI) 
stains the nucleus of necrotic cells red. Intact cells remain unstained. In figure 8, apoptotic (green) (Fig 8B) 
and necrotic (red) (Fig 8A) Balb 3T3 cells are presented. The cells were exposed to 22 µM EnnB for 24 
h and stained with the Annexin V-FITC/PI double stain kit. The proportion of apoptotic vs. necrotic cells 
was determined by flow cytometric measurements.  
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Figure 9. Proportion on apoptotic cells in Balb 3T3 cell cultures post a 24 h exposure.  Exposure to enniatin B (EnnB) had a tendency 
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to the negative control cells. The doses used in this test were determined from previous in vitro toxicity tests.  
  
5.2 Gene expression studies on EnnB 
To give an insight to the mode of action of EnnB, a whole genome gene expression study (Affymetrix gene 
chip array) on rat primary hepatocytes was conducted. As MON induced cytotoxic effects in vitro only at 
extremely high concentrations (in DNA synthesis, ED50 = 800 µM), gene expression studies with MON were 
not carried out. 
5.2.1 Microarray data 
Figure 9. Proportion on apoptotic cells in Balb 3T3 cell cultures post a 24 h exposure.  Exposure to enniatin 
B (EnnB) had a tendency to increase the early apoptotic cell populations compared to the negative control 
cells. EnnB caused pro-a ptotic changes at the same dose and of the same level as the positive control 
camptothecin. MON did not affect the apoptotic cell population compared to the negative control cells. 
The doses used in this test were determined from previous in vitro toxicity tests. 
.2 Gen  expres i n studies on EnnB
To give an insight to the mode of action of EnnB, a whole genome gene expression 
study (Affymetrix gene chip array) on rat primary hepatocytes was conducted. 
As MON induced cytotoxic effects in vitro only at extremely high concentrations 
(in DNA synthesis, ED50 = 800 µM), gene expression studies with MON were not 
carried out.
5.2.1 Microarray data
Genome-wide microarray analysis was carried out using Affymetrix gene chip 
technology. Rat primary hepatocytes were exposed for 1 and 4 h in standard 
conditions to 0 μM, 1 μM, 10 μM, or 20 μM EnnB, representing a negative control, 
a low toxin level, the ED50, and a high level of toxin, respectively. Exposure to the 
low dose of EnnB (1 µM) did not affect the overall gene expression of rat primary 
hepatocytes compared to the negative control, which received only fresh growth 
medium. On the contrary, a 4-h exposure to 10 μM or 20 μM EnnB resulted in an 
altered gene expression profile. The 10 μM concentration compromised the normal 
expression levels most, with 4.8% (985) of the genes in the rat total genome array 
significantly down regulated and only 0.89% (179 genes) significantly up regulated. 
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In total, only 5.7 % of the total rat transcriptome was significantly changed after 
exposure to EnnB. A limit to the log2 fold change (a “100 % “change in expression) 
and a q value ≤ 0.05 were considered significant. 
The smallest dose (1 µM EnnB) upregulated the expression of only 2 genes: an 
unknown gene and Sipa1/2 (signal-induced proliferation-associated 1-like protein 
2), also known as SPAR2, which is involved in GTPase signal transduction, activating 
the small GTPase Rap, reported to regulate spine morphology in hippocampal 
neurons (Spilker, 2008). 
Enrichment analysis of microarray data
A gene ontology enrichment analysis (Fisher’s exact test), using Blast2GO software 
was performed on the array data to examine whether the differently expressed 
genes are overrepresented with regard to specific biological processes (enriched 
gene ontology (GO) terms). A false discovery rate (FDR) value of 0.01 was used 
as a cut-off value. The most enriched down regulated genes belonged to GO terms 
mainly involving catabolic and metabolic processes and the GO term mitochondrion 
organization (GO: 0007005, FDR ≤ 8.4 E-03). These GO terms are listed in Table 
1, article I. Some very modest enrichment was also seen in genes associated with 
apoptotic processes (apoptotic mitochondrial changes), cell signal transduction 
(TOR signaling pathway, ERBB Signaling pathway) MAPK-activated stress cascade, 
and iron-sulfur cluster assembly. Because FDR values were higher than the limit 
for statistical significance, which is FDR ≤ 0.01, they were not analyzed further 
in this work.
No statistically significant enrichment in functional categories of up regulated 
genes could be detected. Modest enrichment (FDR ≥0.01) was discovered in some 
GO terms, namely the protein kinase C-activating G-protein coupled receptor 
signaling pathway, which increases cytoplasmic Ca2+ levels in the cytosol and is 
important in several cell signaling pathways; negative regulation of hexokinase 
activity, which is involved in glycolysis and glycogen production; negative regulation 
of glucokinase activity, with glucokinase acting as a “glucose sensor” in glycogen 
production, and the GO term chromatin organization (Table 1, article I). As the 
data on these particular GO terms were not statistically significant, further studies 
were not carried out.
Cluster analysis of microarray data
As the bioassays had shown significant reduction in ATP production in the cell 
lines, and the GO term mitochondrial organization was statistically significantly 
enriched among downregulated genes, it was chosen for further studies. The GO 
term mitochondrial organization includes 37 down regulated genes, which are 
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summarized in Table 2, article I. The GO term, however, consists of more than 
300 genes (both up- and down regulated in our study), involved in mitochondrial 
assembly, the arrangement of constituent parts, or disassembly (The EBI, 2015). 
Hierarchical clustering analysis (using the Euclidean distance and TMeV 4.9.0 
software) was used to find the genes that “are expressed in the most similar way”. 
The expression pattern of the low dose (1µM) was similar to the negative control, 
and only the high EnnB doses (10 μM and 20 μM) appeared to affect the expression 
patterns of the genes, compared to the negative control. The hierarchical cluster 
analysis revealed three clustered gene sets, two of which consisted of down- 
regulated genes and one of upregulated genes (Fig 10; see also Fig 7 in article I). 
Within the downregulated clusters, two gene families seemed to have several gene 
members included: the Ndufs gene family with the three genes Ndfus1, Ndufs4 and 
Ndufs8, and the Timm gene family with the genes Timm8b, Timm9, and Timm21 
represented. The Ndufs family of genes are NADH dehydrogenase Fe-S proteins, 
and form parts of the iron-sulfur fragment of complex I (GeneCards, 2015) - the 
first enzyme in the electron transport chain in the mitochondrial inner membrane, 
leading to ATP production (Fig. 12). The other family of clustered, downregulated 
genes, the Timm gene family, are involved in the transport of proteins across 
the mitochondrial intermembrane space. In the original array data, a trend of 
downregulation was seen in many genes belonging to both families. However, only 
Ndufs4 gene, Timm21 and Timm8b reached the (self-set) threshold for statistical 
significance (log2 fold change ± 1 or q-value ≤ 0.05, Figure 8 in article I). RT-qPCR 
performed on a few selected genes, including Ndufs4 and Timm21, confirmed the 
results of the microarray, indicating downregulated relative expression if exposed 
(Fig. 9, article I).  
In contrast to the cell proliferation bioassay results performed on the cell lines 
Balb3T3 and HepG2, the microarray gene expression study did not indicate any 
changes in the expression of the key proteins involved in cell proliferation in rat 
primary hepatocytes (Table 3, paper I). Cyclin-dependent kinases, play a major role 
in cell cycle control (Lewin, 2000). The expression of most of these kinases and 
cyclins remained unchanged compared to the unexposed control following exposure 
to EnnB for 4 h. Furthermore, there was no enrichment among functional categories 
involving cell proliferation. This may be because primary cells proliferate poorly 
under in vitro conditions, unless chemically stimulated by growth factors such as 
platelet-derived growth factor (PDGF), and therefore did not provide a means to 
efficiently study this endpoint in our experimental settings. 
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Figure 10. Cluster analysis of genes involved with the GO term mitochondrial organization, following a 4‐h exposure of rat primary 
hepatocytes to 0 µM, 1 µM, 10 µM or 20 µM EnnB. Hierarchical cluster analysis using the Euclidean distance revealed two clusters, 
with downregulated expression patterns (green) in the high doses, containing several genes of the Ndufs and Timm gene families 
(Ndufs1, 4, 8 and Timm 8b, 21 , 9), suggesting an effect of EnnB on the function of the two gene families. Green arrows indicate the 
genes belonging to same clustered gene families (Ndufs or Timm).   
Figure 10. Cluster analysis of genes involved with the GO term mitochondrial organization, following a 
4-h exposure of rat primary hepa ocyt s to 0 µM, 1 µM, 10 µM or 20 µM EnnB. Hierarchical cluster analysis 
using the Euclidean distance revealed two clusters, with downregulated expression patterns (green) in the 
high doses, containing several genes of the Ndufs and Timm gene families (Ndufs1, 4, 8 and Timm 8b, 
21 , 9), suggesting an effect of EnnB on the function of the two gene families. Green arrows indicate the 
genes belonging to same clustered gene families (Ndufs or Timm).
The third endpoint of our in vitro studies was apoptosis. According to flow 
cytometric studies, EnnB slightly increased the early apoptotic cell populations 
of the Balb 3T3 cell line. However, in primary hepatocytes, microarray studies 
did not reveal any significant enrichment of functional categories (GO terms) 
in up- or down regulated genes, indicating that apoptosis is not associated with 
EnnB toxicity in rat primary hepatocytes. Only borderline enrichment among 
down regulated genes was observed (GO terms apoptotic mitochondrial changes, 
FDR ≤ 3.3 E-01, and regulation of apoptotic DNA fragmentation, FDR ≤ 6.4 
E-01). Also the expression of central genes involved in apoptosis (e.g. caspase-3, 
-8, -9, Tradd, Bid, Apaf-1, Aifm) was down-regulated or unchanged compared to 
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the unexposed control in microarray studies (Table 4, article I). The statistically 
significant down-regulation of caspase-3 and Aifm - the main executing molecules 
in apoptosis - further excludes apoptosis as the mechanism of toxicity of EnnB 
(the downregulation can also be seen in Fig 10). In addition, genes involved in 
apoptosis inhibition, c-Jun (fold change 0.8), Birc3 (fold change 0.7), and Faim3 
(fold change 0.8), were somewhat upregulated, compared to negative control 
cells, suggesting the inhibition of apoptotic cascades. The data were confirmed 
by RT-qPCR studies on caspase genes, which did not show significant changes in 
expression levels compared to the unexposed control (Fig. 10, article I). Together, 
these results indicate that apoptotic cell death is not involved in the cytotoxicity 
of EnnB in rat primary hepatocytes.
5.3 In vivo toxicity of MON
5.3.1 Acute oral toxicity of MON
We carried out an oral acute toxicity study (a single-dose, 14-day observation period) 
and determined the acute toxicity levels, clinical symptoms and histopathology of 
the target organs of exposed animals. In addition, the excretion of MON in urine 
and feces was investigated. The process is a stepwise procedure, using three, 9- 10 
week old rats of the same sex at each step. Acute toxicity was determined based on 
the mortality or moribund status of the animals (Fig 11). Our starting dose (high 
dose) of 50 mg/kg b.w. MON, was chosen on the basis of existing in vivo data
All three male rats in the high-dose group (50 mg/kg b.w.), died at 48, 60, and 
83 min post-administration. Signs of toxicity were decreased activity, altered body 
position, respiratory and cardiovascular changes, as well as muscular weakness. 
Decreased activity was already observed 5-10 min post exposure. The rats were lying 
with flaccid tails and eyes slightly open. Unsteady movements and gasping for air 
were recorded. Two of the rats, showed spasmodic jumping preceding death. The 
rats also had a bleached eye color and cardiovascular changes (faint heart beats 
(palpated) in 2 rats, cardiac arrhythmia in 1 rat) in the late phase of the symptoms.
In necropsy, two of the three rats displayed macroscopic changes that included 
unevenly contracted hearts with a dimpled surface and marked congestion in the 
liver. The gastrointestinal tracts were empty. The third rat had normal contents 
in the rectum, but an otherwise empty gastrointestinal tract and no macroscopic 
changes. Microscopically, mild multifocal edema and lymphocytic infiltration in 
the heart muscle was seen in all three animals. No specific changes were reported 
in the other organs. 
As the outcome of the 50 mg/kg b.w. dose was the death of all three rats, the 
next dose to be tested was 10 x lower, i.e. 5 mg/kg b.w. This dose was tested twice. 
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None of the six tested rats in this low dose group showed any clinical signs of toxicity 
and all gained weight until the end of the study. In necropsy, no macroscopic or 
microscopic changes were found and the stomach and intestinal tracts were full 
of normal contents. 
Control animals (1 rat per dose) received 5 or 50 mg/kg b.w. of potassium chloride 
(KCl) in water to ensure that the clinical signs were due to MON, as a potassium salt 
of MON was used in this study. The control animals remained healthy throughout 
the study and gained weight normally. No histopathological changes were reported. 
According to the OECD guideline, our data indicate that MON belongs to category 
2 in the Globally Harmonized System (GHS) of classification, with an LD50 cut-off 
value of 25 mg/kg b.w (Fig 11).
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Figure 11. The stepwise approach used in the acute toxicity test. Three animals (rats) are used per step and the mortality of the 
starting dose determines the next fixed doses, and finally the category of toxicity of a substance. Dark gray arrows indicates the 
test procedure in our study on MON toxicity and the determination of an LD50 value of 25 mg/kg b.w. The figure is adapted from 
OECD Guideline 423. 
 
To further assess the doses to be used in the subacute study, three rats were ,respectively, dosed with 40 
mg / kg b.w., 25 mg/ kg b.w, or 10 mg/kg b.w. MON. The single rats dosed with 40 and 20 mg/kg b.w., 
Figure 11. The stepwise approach used in the acute toxicity test. Three animals (rats) are used per step and 
the mortality of the starting dose determines the next fixed doses, and finally the category of toxicity of a 
substance. Dark gray arrows indicates the test procedure in our study on MON toxicity and the determination 
of an LD50 value of 25 mg/kg b.w. The figure is adapted from OECD Guideline 423.
To further assess the doses to be used in the subacute study, three rats were, 
respectively, dosed with 40 mg / kg b.w., 25 mg/ kg b.w, or 10 mg/kg b.w. MON. 
The single rats dosed with 40 and 20 mg/kg b.w., displayed similar signs as the rats 
tested with the high dose (50 mg/kg b.w. MON), with decreased activity, altered 
body position, gasping for air, and cardiovasc lar changes, followed by death at 
75 min and 60 min, respectively, post dosing. The third rat, dosed with 10 mg/
kg b.w., showed decreased activity, altered body position, respiratory changes, 
trembling, and piloerection for 3 hours post-dosing. However, the rat recovered in 
48 h, after which it was euthanized and a full necropsy was performed, especially 
to determine adverse effects on the heart tissue. 
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The rats dosed with 25 mg/kg b.w. and 40 mg /kg b.w. had marked congestion 
in the liver, but no other specific microscopic changes were present. Both rats had 
an otherwise empty gastrointestinal tract, but the one dosed with 40 mg/kg b.w. 
had normal contents in the rectum. The rat dosed with 10 mg/kg b.w. MON had 
acute purulent pneumonia, which was not likely to have been caused by MON, but 
no other macroscopic or microscopic changes could be detected.
Excretion studies on MON were performed using an in-house validated liquid 
chromatography- quadrupole-time-of-flight mass spectrometry (UPLC-Q-Tof-MS) 
method and a hydrophilic interaction chromatography column (HILIC) (section 2.5, 
article II). Urine and fecal samples were collected at pre-defined time points from 
surviving animals (5 mg/kg b.w. dose) until the end of the study. MON was rapidly 
excreted into urine, with the highest amounts detected only 6 hours post-dosing and 
most MON was excreted within the first 24 h. At 48 h post-dosing MON was no 
longer detectable in urine. The excretion in feces was very low (< 1% of administered 
dose), indicating that excretion via the biliary pathway is not significant.
5.3.2 Repeated dose oral toxicity study of MON
To further examine the toxic impact of synthetic MON (as a potassium salt) in 
vivo, and particularly the health effects of repeated oral low dose exposure in 
rats, we applied an adaption of OECD Guideline 407 on Sprague–Dawley rats, for 
28-days. We used five dose groups (exposed to 3, 6, 9, 12 or 15 mg/kg b.w. MON 
by gavage), each consisting of five, 9-10 week old, male Sprague Dawley rats. We 
also used two satellite groups, dosed with 12 and 15 mg/kg b.w. MON, to examine 
possible delayed toxic responses and recovery. These rats were kept alive for 2 
weeks after the completion of the study. Control rats only received filtered tap 
water. Three animals of each tested dose group were housed in metabolic cages, 
to collect urine and feces samples, and the rest of the rats were maintained in 
standard plastic cages. Urine and fecal samples were collected at set time points 
daily and blood samples once a week. Clinical assessment took place twice a day. 
A full post mortem necropsy was performed on all rats.
Four rats out of 40 died and all of these belonged to the two highest dose groups: 
two rats in the 15 mg/kg b.w., showed decreased activity and somnolence, and died 
of acute heart failure at days 4 and 21. These two rats had pulmonary congestion 
and leukostasis, but otherwise normal findings at necropsy. One of them had slightly 
blood stained contents in the small intestine. One rat in the 12 mg/kg b.w. group 
and one rat in the 15 mg/kg b.w. satellite group died or was euthanized due to 
respiratory distress caused by dosing by gavage and showed pulmonary congestion, 
but no other specific changes were found at necropsy.
One rat in the 9 mg/kg b.w. group was reported to show symptoms similar to the 
two rats that died of cardiac failure (somnolence, withdrawal, decreased activity) but 
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survived until the end of the study and had no macroscopic or microscopic changes, 
as was the case for all the other rats that survived (3, 6 and 9 mg/kg b.w. doses). 
All rats in the lower dose groups (3, 6 and most 9 mg/kg b.w. MON) remained 
clinically healthy and gained weight until the end of the study. 
No statistically significant changes in feed or water consumption, body weight, 
relative organ weights (thymus and spleen weights in relation to body weight ) or 
blood parameters could be detected in any of the tested groups or the negative 
control group ( Fig 1, article III)
The impact of MON on the innate immunity was assessed as changes in 
neutrophil activity of the blood samples, using a novel chemiluminescence assay 
developed at the University of Turku by Drs. Atosuo and Lilius (article III). At the 
end of the study (day 28), the phagocytic activity of the neutrophils was significantly 
reduced in all dose-groups, compared to the negative control group. On average the 
activity was reduced to 48 ± 8 % and was not dose dependent, with a severe reduction 
also recorded in the lowest dose group (3 mg/kg b.w.) (Fig 2, article III). MON did 
not, however, cause changes in neutrophil or total leucocyte counts. Interestingly, 
the reduction in neutrophil activity continued in the satellite groups, even after 
cessation of exposure (to 28 %), suggesting sustained damage to neutrophils.  
Excretion studies were performed with the same in-house validated liquid 
chromatography quadrupole-time-of- flight- mass spectrometry (UPLC-Q-Tof-MS) 
method used in the acute oral toxicity study. Urine and fecal samples were collected 
daily and all the urine samples of the first week and samples of the 1st, 3rd, and 6th day 
of the following weeks were analyzed. The excretion to urine was constant between 
the three first weeks and the mean excretion ranged between 29 – 31.5 %. During 
the 4th week, excretion was reduced by another 10% - 20.2% of the dosed MON. 
Our repeated 28-day oral toxicity study indicated that MON is acutely toxic to rats 
and causes mortality by heart failure and symptoms of acute toxicity at doses greater 
than 9 mg/kg. At lower doses, MON causes no clinical signs of toxicity. However, it 
does affect innate immunity, reducing the phagocytic activity of neutrophils, even 
at the lowest tested dose. Our data allow us for the first time to propose a LOAEL 
value of 3 mg/kg b.w. for MON. MON is rapidly excreted and independently of 
the dose into urine, proven by both the acute and repeated dose study. However, 
only 20.2-31.5 % (mean excretion) of the dosed MON was excreted as the parent 
compound. 
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6. DISCUSSION
Food and feed safety is nowadays taken for granted in the EU and other 
industrialized countries due to efficient surveillance programs and legislation. 
However, globalization and climate change have increased the risk of exposure 
to harmful chemicals, particularly to natural toxins and other substances via food 
consumption, bringing new challenges to food safety. The aim of this study was 
to elucidate the toxicity and mechanism of toxicity of two Fusarium mycotoxins, 
EnnB and MON, both common findings in Finnish grain and grain products. 
Although Enns and MON have not been reported to be involved in any human 
outbreaks, harmful effects on humans and livestock cannot be ruled out, especially 
on a long-term and low-dose basis, as toxicity data are very limited.
In vitro, the study focused on three main aspects of toxicity: 1) cellular energy 
production 2) cell proliferation and 3) cell death. Furthermore, the mode of action 
of EnnB was pursued by means of gene expression, conducting a rat whole-genome 
gene expression study. Rat primary hepatocytes were used, as they are considered 
to better correspond to in vivo studies than immortalized cell lines. The in vivo 
studies focused on the oral toxicity of MON, as it has frequently been found at 
low levels (up to 810 µg/kg in wheat) in Finnish grain(Jestoi, 2005), and might 
pose an unidentified risk of a daily low-level exposure in the Finnish population. 
Hence, an acute oral toxicity test and a repeated-dose oral toxicity test on rats were 
performed, as no animal studies had been conducted using synthetic MON. The 
few existing animal studies had been performed using MON, purified from fungal 
cultures, possibly including remains of other mycotoxins, as well (Kriek et al., 1977, 
Abbas et al., 1990).  
6.1 Toxicity and mechanism of action of EnnB
Enns have been reported to be cytotoxic in a wide variety of cell lines in vitro over 
the years. Gammelsrud et al. (2012) reported immunotoxic responses and reduced 
lysosomal activity in mouse RAW 267.4 macrophages. Lysosomal disruption 
and increased necrotic cell death in human colon adenocarcinoma Caco-2 cells 
(Ivanova et al., 2012) and inhibition of enzyme activity (e.g. acyl-CoA: cholesterol 
acyltransferase (ACAT) in rat liver microsomes have also been reported (Tomoda 
et al., 1992). Surprisingly, the toxicity of Enns in vivo has been low, with an LD50 
value as high as 350 mg/kg b.w. for a mixture of Enns, called Fusafungine (Berdy, 
1980). One explanation could be a rapid biotransformation involving CYP450 
enzymes and a fast elimination in vivo (Fæste et al., 2011). Being highly lipophilic 
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compounds, Enns could, however, accumulate in the body, possibly causing toxicity 
over time. Indeed, Enns have been shown to bioaccumulate in eggs (Jestoi et al., 
2009) and have been recovered, at low levels, from broiler meat, liver, and skin 
(CODA-CERVA, 2011-2012).
Enns are known to form sandwich-structured dimers, transporting cations 
(especially K+) across biological membranes (Ovchinnikov et al., 1974, Kamyar et 
al., 2004), and the toxic impact is thought to be due to an altered ion concentration 
in cells. However, the exact mechanism of action is still unclear.  
Our data point to an alteration in the energy metabolism of mouse Balb 3T3 
fibroblasts, human hepatocellular carcinoma HepG2 cells, and in rat primary 
hepatocytes. ATP levels in the cell cultures of the cell lines (Balb 3T3, HepG2) were 
significantly reduced at relatively low (< 10 µM) concentrations, indicating toxicity. 
The reduction could be due to a reduced cell number in the cultures compared to 
the negative control cells, possibly due to a decrease in cell proliferation, as no cell 
lysis was observed (by AK-bioassay or light microscopy). Furthermore, the results 
of the gene expression study on rat primary hepatocytes indicated that EnnB alters 
the ATP production of cells due to effects on the ETC.  The enrichment analysis 
of microarray data (from primary hepatocytes) revealed that genes involved in 
metabolic and catabolic processes were generally down regulated and enrichment 
was also seen in the downregulated genes belonging to the GO term linked with 
“mitochondrion organization”. This could refer to mitochondrial dysfunction and 
consequently energy deprivation in cells. No enrichment among any up regulated 
genes was detected. Further studies on the impact of EnnB on the mitochondrion 
was conducted by means of hierarchical cluster analysis of the 300 genes (both 
up- and downregulated) belonging to the GO term “mitochondrion organization”. 
Three gene clusters could be distinguished: two consisting of downregulated genes 
and one of upregulated genes. In the downregulated clusters, two gene families 
had several members included - the Ndufs gene family, with 3 members (Ndufs1, 
4, and 8) and the Timm gene family, with two members (Timm21 and 8b). The 
Ndufs gene family members are involved in cellular respiration (ATP production), 
as they are subunits of the mitochondrial electron transport chain (ETC) protein 
complex I (Breuer et al., 2013, Mimaki et al., 2012). Complex I is the largest enzyme 
complex of the ETC, consisting of 45 subunits, and its functions include binding 
and oxidizing NADH and transferring (2) electrons to the next carrier of the ETC, 
ubiquinone (Fig. 12). The energy derived from the electron transfer is used to pump 
protons (H+) into the intermembrane space in mitochondria. 
Complex I is divided into the N-module, oxidizing NADH, the Q-module, 
transferring the electrons to ubiquinone, and the P-module, translocating protons 
to the mitochondrial intermembrane space, producing the proton gradient used by 
ATP synthase in ATP production (Mimaki et al., 2012). The gene products of the 
Ndufs genes are NADH-dehydrogenase iron-sulfur protein subunits (Breuer et al., 
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2013, Gene Cards, 2015). The iron-sulfur protein cluster of complex I and flavin 
mononucleatide are responsible for the transfer of the electrons to ubiquinone 
(Garrett and Grisham, 1999). Ndufs1 gene product makes up the largest subunit 
of complex I and is a part of the N-module, responsible for the binding and 
oxidation of NADH, whereas Ndufs8 is a part of the P-module, pumping protons 
into the intermembrane space (Mimaki et al., 2012). The Ndufs4 gene encodes an 
18 kDa subunit, phosphorylated by intracellular cAMP, leading to the maturation 
and assembly of complex I (Breuer et al., 2013). Complex I deficiency patients, 
with mutations in the Ndufs4 gene, develop an early-childhood fatal Leigh-like 
syndrome, leading to lesions in different parts of the brain. In the fibroblasts of 
these patients, an altered mitochondrial membrane potential, NADH levels, and 
changes in mitochondrial morphology have been reported (Breuer et al., 2013). 
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Figure 12. The gene expression data indicate that EnnB affects the electron transfer chain (ETC) of the mitochondrion, suggesting 
reduced cellular energy (ATP) production in vitro. The expression of some genes belonging to the Ndufs gene family, forming a part 
of the iron‐sulfur fragment of complex I, the first enzyme of the ETC, was down regulated (Ndufs 1, 4, and 8), possibly interfering 
with the normal assembly and functioning of complex I and hence the electron transport chain and ATP production. 
Downregulation of Timm21, belonging to the other clustered gene family, might further contribute to the dysfunction of complex I, 
as the gene product is a translocase of the mitochondrial inner membrane and is needed for complex I assembly. 
 
Figure 12. The gene expression data indicate that EnnB affects the electron transfer chain (ETC) of the 
mitochondrion, suggesting reduced cellular energy (ATP) production in vitro. The expression of some 
genes belonging to the Ndufs gene family, forming a part of the iron-sulfur fragment of complex I, the first 
enzyme of the ETC, was down regulated (Ndufs 1, 4, and 8), possibly interfering with the normal assembly 
and functioning of complex I and hence the electron transport chain and ATP production. Downregulation 
of Timm21, belonging to the other clustered gene family, might further contribute to the dysfunction of 
complex I, as the gene product is a translocase of the mitochondrial inner membrane and is needed for 
complex I assembly.
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The product of the Timm21 gene, belonging to the other family of clustered genes, 
is a translocase of the mitochondrial inner membrane and is required for the 
assembly of complex I and complex IV (Gene Cards, 2015). Down regulation of 
Timm21 further contributes to the idea of EnnB causing adverse effects on complex 
I and electron transfer. The Timm 8b gene product guides membrane proteins 
through the intermembrane space, as they are embedded in the inner membrane 
of the mitochondrion (The NCBI, 2015). RT-qPCR studies performed to confirm 
array data findings also revealed a trend of down- regulation in both the Ndufs and 
Timm gene families. In particular, downregulation of the Ndufs family of genes 
and Timm21, could indicate that EnnB exposure may alter the function of the 
mitochondrial electron transport chain (ETC) due to effects on complex I function 
and assembly, and hence, dramatically reduce ATP production, resulting in energy 
depletion of the cell. This could provide an explanation for the rapid necrotic death 
of the rat primary hepatocytes and the drastic drop in ATP production in the cell 
lines (Balb 3T3, HepG2). Our results are in line with studies by Tonshin et al. 
(2012), who reported that Enns caused mitochondrial alteration and dysfunction in 
isolated rat liver mitochondria and human neural (Paju) cells, murine insulinoma 
(Min-6) cells, as well as in boar sperm cells.
Enns caused a drop in the inner membrane potential and swelling of the isolated 
rat mitochondria in the presence of potassium (K+) (Tonshin et al., 2010). A loss of 
mitochondrial membrane potential was also discovered in intact Paju- and Min-6 
cells (Tonshin et al., 2010), and Caco-2 cells (Ivanova et al., 2012) causing necrotic 
cell death. In sperm cells, Enns caused a partial depolarization of mitochondria 
as a result of K+ influx into the mitochondrial matrix (causing swelling), and 
hyperpolarization of the sperm plasma membrane due to the efflux of potassium 
ions from the cell cytoplasm to the medium (Tonshin et al., 2010).
A number of chemicals and drugs act by altering mitochondrial function. However, 
the mechanism of action might be very different depending on the chemical. The 
effects can be directly targeted at the DNA transcription of ETC complexes or at the 
inhibition of enzyme activity of the ETC and glycolysis or beta-oxidation. Chemicals 
can also act as oxidative phosphorylation uncouplers, as does the proton ionophore 
2, 4-dinitrophenol, carrying protons across the inner membrane, decreasing the 
H+ gradient across the mitochondrial inner membrane, and hence leading to the 
formation of heat instead of the synthesis of ATP (Modica-Napolitano et al., 2003). 
Enhancement of free radical production might lead to imbalanced antioxidant levels 
and damage the enzymes of the ETC and other cell components (Neustadt and 
Pieczenik, 2008, Modica-Napolitano et al., 2003). Oxybarbiturates (Amytal), the 
neuroleptics haloperidol and risperidone, as well as the pesticide rotenone, are 
examples of chemicals inhibiting the action of complex I, thereby reducing electron 
transfer and oxidative phosphorylation (ATP production) (Neustadt and Pieczenik, 
2008, Alridge and Partker, 1960, Li et al., 2003). Haloperidol and risperidone 
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inhibit the NADH-CoQ reductase activity of complex I (Modica-Napolitano et al., 
2003), whereas rotenone inhibition of complex I leads to elevated ROS production 
(especially superoxide).
High ROS concentrations can cause further mitochondrial damage and have also 
been reported to be linked to increased levels of apoptotic cell death (Li et al., 2003). 
However, Dornetshuber et al. (2009a), reported that Enns do not cause oxidative 
stress in HL-60 leukemia cells or cervix carcinoma KB 3-1 cells, and Ivanova et al. 
(2012), reported increased necrosis in Caco-2 cells induced by EnnB, rather than cell 
death by apoptosis. In fact, chemicals that only inhibit complex I function (NAHD 
oxidation) do not necessarily reduce ATP levels as drastically as EnnB in our study, 
as complex II still functions by delivering electrons from FADH2 (succinate) to the 
ETC. Hence, The decrease in ATP levels in the cell line cultures (Balb 3T3 and 
HepG2) could be explained by reduced cell number and a possible effect on ATP 
production, indicated by studies on EnnB exposed primary hepatocytes, with an 
altered ATP production via effects on the ETC Complex I transcription.
EnnB has also been reported to lower the mitochondrial inner membrane 
potential, which could lead to dysfunction of ATP synthase (Tonshin et al., 2010, 
Ivanova et al., 2012). Thus, EnnB may affect the energy metabolism of the cell 
(mitochondria) by a) affecting ionophoric properties (cation transport), leading 
to disruption of the mitochondrial inner membrane potential, and b) altering the 
assembly and function of the ETC complex I, possibly due to reduced transcription 
of the Ndufs family of genes and Timm21. This could limit electron transfer and 
inhibit the maintenance of the proton (H+) gradient in the intermembrane space 
by the ETC. Together, these two effects can lead to dysfunction of ATP synthase 
and drastically reduce ATP levels in the cell. 
Another of our findings was that EnnB exposure altered cell proliferation in the 
cell lines (Balb 3T3 and HepG2), possibly as a response to energy deprivation. The 
cells remained intact but DNA synthesis and dividing of cells ceased. In contrast, 
the primary hepatocytes, died via necrotic cell death already at concentrations as 
low as 10 µM EnnB and hence, seemed to be more sensitive. The use of higher 
doses (> 200µM) could have finally resulted in necrotic cell death also in the cell 
lines (Balb 3T3 and HepG2). One reason for the different outcome of primary 
hepatocytes and cell lines could be a higher energy demand of primary cells, as 
they still have high enzyme activity, some of which may be lost in the transformed 
cell line HepG2 and absent in Balb 3T3 cells. Therefore, energy deprivation by 
EnnB might lead to the death of primary cells following exposure to lower toxin 
concentrations than in cell lines. 
Biotransformation involving CYP450 enzymes could provide another explanation 
to the differences in toxic responses of cell lines vs primary cells and in vivo settings. 
Fæste et al. (2011) discovered 12 different metabolites of EnnB (M1-M12), in 
exposed rat -, dog-, and human microsome preparations, resulting from oxidation 
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or demethylation reactions. Furthermore, the half –life of EnnB in the preparations 
was short, only 12-32 min. The biotransformation of EnnB was inhibited most (62%) 
in the human microsome preparation by blocking (phase I) P450 enzyme CYP3A4, 
present mainly in liver cells. As the HepG2 cell-line has been reported to have a 
weak P450 gene expression and activity compared to human hepatic primary cells 
(Gerets et al., 2012), biotransformation of EnnB would not occur effectively, hence 
leading to cytotoxic effects (Cell cycle arrest and reduced ATP levels) by EnnB in 
the cell lines. In in vivo settings, biotransformation reactions and elimination of 
EnnB from the body occurs fast and efficiently, hence, preventing toxic insults and 
being less toxic in vivo than in vitro.  In primary cells biotransformation reactions 
via P450 enzymes might be effective, however, a well known fact of xenobiotic 
metabolism is that some of the metabolites are very reactive and can be more toxic 
to the target than the actual toxin itself. If reactive metabolites are formed, primary 
cells may not be able to eliminate them, leaving the metabolites inside the cell or 
in the culture medium, possibly causing some of the cytotoxic effects. 
Low levels of EnnB had a strong impact on cell proliferation in Balb 3T3 and 
HepG2 cells (ED50 = 4 μM and 0.5 µM, respectively). The effect was even stronger 
than for ATP production, but still lay within the same concentration range. The 
differences might be due to the different sensitivity of the two test methods. The 
mitotic cell cycle is a complex and highly regulated process ending in the mitotic 
division of a cell into two daughter cells. Cyclin-dependent kinases and regulators are 
mainly responsible for the cell cycle control (For a review see Lewin, 2000). Cyclin-
dependent kinases (Cdk) are made up from a catalytic kinase and a regulatory cyclin, 
needed for activity and substrate specificity. The different stages of the cell cycle in 
animal cells are controlled by different kinase subunits and cyclins. For example, 
Cdk4, 6–cyclin D dimers are involved in the regulation of the G1 phase, the first phase 
of the interphase of the cell cycle, whereas Cdk2–cyclin E or A are active in the S 
phase (= DNA replication) (Lewin, 2000). Our data on reduced cell proliferation are 
in line with the results of Gammelsrud et al. (2012), from RAW 267.4 macrophages, 
reporting reduced mitochondrial metabolic activity and reduced cell proliferation 
due to cell cycle arrest in the G0/G1 phase, with a concomitant decrease in cyclin 
D1 levels in exposed cells. D cyclins are short lived and their synthesis is inhibited 
if growth factors are not present, and low cyclin D levels might be the signal for 
cells to enter the G0 phase if growth conditions are altered (Lewin, 2000). Cell 
cycle arrest by EnnB in the G2 phase in Caco-2 cells was also reported by Ivanova 
et al. (2012). Hence, ATP depression due to the effects of EnnB on ETC complex 
I, might be the explanation to the decreased cell proliferation (DNA synthesis) in 
the cell lines Balb 3T3 and HepG2.  
Gene expression studies on rat primary hepatocytes did not confirm any changes 
in the key proteins of the cell cycle compared to the negative control, except for 
cyclin B, which was down regulated. Cyclin B is only active during mitosis and is 
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extensively produced during late interphase (G2/M). No significant enrichment 
(GO terms) among up- or downregulated genes involving cell proliferation was 
detected. This result was, however, expected, as primary cells do not proliferate 
unless stimulated by growth factors (e.g. platelet derived growth factor) and are not 
a good tool to study cell proliferation. However, our study confirmed that the toxicity 
of high doses of EnnB (greater than 10 μM) is not due to arrest in cell proliferation 
in rat primary hepatocytes, but rather an event of necrotic cell death, manifested by 
swelling of the cells and their detachment from the cell culture plate, most likely due 
to energy deprivation caused by mitochondrial dysfunction (effects on complex I). 
The last endpoint we focused on was programmed cell death, or apoptosis. 
In contrast to necrosis, apoptosis does not cause an inflammation reaction in 
tissues. Instead apoptotic cells undergo typical morphological changes, such as 
nuclear fragmentation, chromatin condensation, DNA fragmentation, and cell 
membrane blebbing. A number of chemicals increase apoptotic cell death, and it 
is not unusual that low levels of chemicals or toxins induce apoptosis, but higher 
doses lead to death via necrosis (see review by Lewin, 2000, and by Elmore S., 
2007,). Two separate apoptotic pathways exist: the death receptor pathway and 
the mitochondrial pathway. Briefly, the death receptor pathway is activated as 
apoptosis stimulating fragment (Fas) or tumor necrosis factor (TNF) ligands binds 
to receptors on the cell surface and activate a series of cysteine-aspartic proteases 
(caspases) responsible for typical apoptotic changes in the cell. Activation of 
caspase-3, the main executioner caspase, finally activates DNA fragmentation factor 
40 (DFF40), involved in DNA fragmentation and chromatin condensation (Widlak 
and Garrard, 2005). The contents of the apoptotic cells are packed in apoptotic 
bodies, which are phagocytosed by surrounding macrophages and parenchymal 
cells and degraded. An inflammatory reaction is avoided as cell contents is not 
released into the surroundings. Furthermore, the phagocytosing macrophages do 
not produce cytokines (Elmore S., 2007).
The mitochondrial pathway is triggered by certain stimuli (e.g. toxins, viruses, 
loss of growth factors) resulting in the formation of a mitochondrial permeability 
transition pore (MPT)  and cytochrome C release from mitochondria, as well as 
SMAC proteins (second mitochondria-derived activator of caspases). Cytochrome C 
release also activates caspase-9 and caspase-3. The protein Aif (apoptosis inducing 
factor) is released from mitochondria to the nucleus and causes DNA fragmentation 
independent of caspases (Lewin, 2000, Elmore S., 2007).
Flow cytometric measurements of EnnB-exposed mouse fibroblast Balb 3T3 
cells, revealed a slight increase in the early apoptotic cell population. The effect 
was comparable to the positive control camptothecin. The proportion of the pro-
apoptotic cell population increased with the rising dose after 24 h and ranged from 
0.3% (unexposed cells) to 4.4% (45 µM EnnB exposure). A 48-h exposure had similar 
effects. Furthermore, the proportion of late apoptotic or necrotic cells appeared to 
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increase as a function of the EnnB dose, although the change was not statistically 
significant. EnnB has previously been reported to induce apoptotic changes, such 
as caspase -3/7 activation in hepatoma H4IIE cells (Wätjen et al., 2009), caspase-7 
activation in the KB-3-1 cell line, and nuclear fragmentation (Dornetshuber-Fleiss 
et al., 2014). However, Ivanova et al. reported necrotic cell death in Caco-2 cells 
rather than apoptosis (Ivanova et al., 2012). Our studies revealed a slight increase 
in pro-apoptotic cell populations in Balb 3T3 cells, although most cells survived. 
The outcome of our gene expression studies on rat primary hepatocytes did 
not support apoptotic cell death. The morphological findings (swelling of cells, 
rupture of plasma membrane) already pointed towards necrotic cell death, and the 
gene expression results supported this, as no enrichment was detected among the 
up-regulated genes related to apoptosis. Furthermore, the only GO terms linked 
to apoptosis (apoptotic mitochondrial changes and regulation of apoptotic DNA 
fragmentation) were slightly (but not statistically significantly) enriched among 
down regulated genes. The central genes involved in apoptosis were not upregulated 
(e.g. caspase-3,-8,-9, TRADD, Bid, Apaf-1, Aifm), instead slightly down-regulated 
or unchanged compared to the negative control in the microarray experiment, 
providing further evidence against apoptotic cell death. RT-qPCR studies on 
selected central genes (caspase-3 and Aifm) also revealed down regulated expression. 
Furthermore, the c-JUN gene, involved in apoptosis inhibition via the TNF/NF-KB/
IAP pathway, was marginally up-regulated (log2-fold change 0.8).
 The significance of apoptotic cell death in the overall toxic response of Balb 
3T3 cells to EnnB could be considered minor, as the increase in the early apoptotic 
cell population was less than5 % compared to the negative control and most cells 
survived. According to our results, cell death in primary hepatocytes was necrotic 
rather than apoptotic. However, the importance of apoptotic cell death in the toxic 
outcome of Enns propably differ between cell types, as confirmed by previous studies 
and according to the dose (Ivanova et al., 2012, Wätjen et al., 2009, Dornetshuber-
Fleiss et al., 2014). It appears that Enns may cause both apoptosis and necrotic cell 
death, as shown in our study. This could be explained by the finding of Ivanova et 
al., (2012) who reported disruption of the lysosomal membranes in Caco-2 cells, 
which leads to the leakage of acidic hydrolases and cathepsins into the cytosol. 
Hydrolases digest cytoplasmic proteins vital to the cell and can lead to cell death 
by necrosis (Boya and Kroemer, 2008). Indeed, Ivanova et al. (2012) reported 
necrotic cell death of Caco-2 cells. However, it is possible that released cathepsins 
activate caspases and introduce apoptotic cell death (Boya and Kroemer, 2008). 
Enns appears to introduce many different toxic manifestations in a variety of 
cells. High doses of Enns may cause direct toxic insult by inducing an imbalance 
in the ion concentration of the cytoplasm because of the ionophoric and lipophilic 
nature of the molecule (Ovchinnikov et al., 1974). The transport of high amounts 
of cations through the plasmalemma may lead to swelling and uncontrolled cell 
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death by necrosis. According to published data, Enns have been reported to cause 
lysosomal disruption (Ivanova et al., 2012), alteration of ATP-driven efflux pumps 
(Dornetshuber et al., 2009b) , cell cycle arrest (Dornetschuber et al., 2007, Devreese 
et al., 2013), a reduction in mitochondrial metabolism, the loss of membrane 
potential, and ATP production (Tonshin et al., 2010 ) , enzyme inhibition (Tomoda 
et al., 1992), apoptosis (Wätjen et al., 2009) and changes in calmodulin-dependent 
signaling (Mereish et al., 1990). 
Our results indicated reduced cell proliferation and ATP production, possibly 
due to effects on the down regulation of central ETC complex I genes. Furthermore, 
EnnB slightly increased apoptotic cell death in the cell line Balb 3T3 and necrotic 
cell death in primary hepatocytes. Traditionally, Enn toxicity has been seen as a 
direct assault due to ionophoric properties, resulting in e.g. cytoplasmic ion balance 
or lysosomal disruption. However, reduced ATP production, due to effects on the 
mitochondrial inner membrane potential and ETC complex I, can account for an 
equally significant part of Enn toxicity, especially at lower concentrations, leading to 
other manifestations, such as reduced cell proliferation, cell cycle arrest, apoptosis, 
and necrosis. 
6.2 Toxicity of MON in vitro and in vivo
MON is frequently found in grain at low concentrations (< 810 µg/ kg) in Europe, 
with the highest measured concentration in maize from Poland, 425 mg/kg 
(Logrieco et al., 1993). In a Finnish survey in 2001, 74% of all grain samples 
contained MON, although, at low concentrations (0 - 810 µg/kg grain), often 
associated with F. avenaceum infection (Jestoi, 2005, Jestoi et al., 2004). Hence, 
there is a risk of chronic human and animal exposure to low levels of MON. Despite 
the global and frequent distribution of MON in grain products, only a few in vivo 
studies have been conducted, and the significance of the exposure is unclear. To 
provide additional knowledge, we decided to examine the acute and subacute 
(repeated low dose) toxicity of a synthetic potassium salt of MON in male Sprague-
Dawley rats, according to OECD Guidelines 423 and 407.
In this study, the acute oral toxicity and the subacute oral toxicity of MON in 
male Sprague-Dawley rats was studied by adapting OECD Guidelines 423 and 407. 
The OECD Guideline 423 toxicity study is a single-dose, 14-day acute oral toxicity 
study, aiming at minimizing the number of used animals, without compromising 
the reliability of the results. It is a stepwise procedure with the use of 3 animals of 
a single sex per step. The range of acute toxicity of the test substance depends on 
the mortality or moribund status of the animals. Both sexes are normally tested, 
however, in order to further reduce the number of rats used, we chose to test only 
males, as they were considered more sensitive than females in previous studies 
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by Kriek et al. (Kriek et al., 1977). This method enables the classification of test 
compounds into different categories of toxicity and to estimate the LD50 for the 
toxins (Fig. 2 in article II). Furthermore, the results were used to select exposure 
levels for a subsequent subacute toxicity study. The purpose of the subacute toxicity 
study (OECD Guideline 407) was to provide information on possible health effects 
arising from repeated-dose exposure to MON over a limited period of time (28-
days). A 28-day period in rats is equivalent to 2-years in human lifetime (Agoston, 
2017). The in vitro toxicity of MON was also assayed, mainly using the Balb 3T3 
cell line, with the same end points as for EnnB – cell membrane integrity, ATP 
production, and cell proliferation (DNA synthesis). 
Our data indicated clear acute toxicity of MON in rats, with an LD50 cut-off 
value of 25 mg/kg b.w. Additional studies that were performed to help refine the 
doses to be used in the subacute study, pointed towards an even lower LD50 value, 
ranging between 10-15 mg/kg b.w. Acute toxic signs (mainly cardiac and respiratory 
changes) were reported at doses of 25-50 mg/kg b.w. The tested low dose (5 mg/ 
kg b.w.) did not induce clinical toxicity or histopathological changes. 
The outcome of the subacute study (28-day repeated dose study) was in line 
with the acute study, as 2 rats of 5 in the highest dose group (15 mg/kg b.w.) 
died of acute heart failure and 1 rat of 5 in the 9 mg/kg b.w. dose group showed 
similar toxic signs, but survived the study. Low doses (3-6 mg/kg b.w.) did not cause 
acute clinical signs in the rats. No significant histopathological changes could be 
detected. In the literature, MON has been reported to cause heart muscle damage, 
ventricular arrhythmia and heart failure in rats (Kriek et al., 1977b, Zhao et al., 1993, 
Lili et al., 1991) providing support to our results. Kamyar et al. (2006) reported 
that MON reduced in vitro the contractile force of guinea pig papillary muscles, 
which normally prevent the mitral- and tricuspid valves from opening in the wrong 
direction during ventricular systole (Kamyar et al., 2006). No changes in action 
potentials or intracellular ion concentrations of the papillary cells were reported. 
MON has been reported to reduce the energy metabolism of cells by inhibiting 
the action of the enzyme pyruvate dehydrogenase during glycolysis (Fig 13), hence 
preventing the oxidation of pyruvate to acetyl-CoA and its incorporation into the 
TCA cycle (Burka et al., 1982, Gathercole et al., 1986, Pirrung and Nauhaus, 1996). 
Burka et al. (1982) suggested that the inhibition is due to the structural similarity 
of MON and pyruvate, whereas Pirrung et al. (1996) proposed a reaction between 
the carbonyl of MON and the co-factor thiamine, as MON also inhibited other 
thiamine-dependent enzymes (yeast pyruvate decarboxylase, aceto-hydroxy acid 
synthase) (Pirrung and Nauhaus, 1996). The chemical arsenic also inhibits pyruvate 
dehydrogenase by binding to thiols (Samikkannu et al., 2003). MON was additionally 
reported to inhibit ɑ-ketoglutarate dehydrogenase (Burka et al., 1982) of the TCA 
cycle (Fig 13). The energy deprivation caused by MON could explain the cardiac 
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manifestations, arrhythmia and death due to cardiac arrest, as cells with high energy 
demands would be most affected. 
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production (Pirrung and Nauhaus, 1996, Burka et al., 1982, Gathercole et al., 1986). Hence, energy production in the cell could be 
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Figure 13. Moniliformin (MON) has been proposed to inhibit the oxidation of tricarboxylic acid (TCA) cycle 
intermediates by substituting pyruvate, leading to reduced amounts of NADH, which is normally used in 
oxidative phosphorylation and ATP production (Pirrung and Nauhaus, 1996, Burka et al., 1982, Gathercole 
et al., 1986). Hence, energy production in the cell could be altered and this would be likely to have the 
greatest effect on cells with a high energy demand, such as heart muscle cells.
The subacute study also demonstrated, somewhat unexpectedly, that MON alters 
innate immunity by reducing the phagocytosis of neutrophils by 50% in all dose 
groups, even in the lowest tested dose group of 3 mg/kg b.w., compared to the 
negative control. The reduction continued in the satellite group, even after dosing 
was ceased, suggesting a prolonged effect and increase in the susceptibility of 
the test animals to bacterial infections. Bacterial infections were, however, not 
detected possibly due to a clean and optimized environment (laboratory). Hence, 
we suggested a LOAEL of 3 mg/kg b.w. for MON. A similar reduction in phagocytic 
activity of neutrophils was found in myeloid leukemia patients, caused by reduced 
myeloperoxidase (MPO) activity (Anand et al., 2005). MPO converts superoxide 
into hypochlorous acid, responsible for bacterial destruction in the neutrophil 
phagosomes. As MON did not reduce the neutrophil or total leucocyte counts, 
a reduction in MPO activity could explain the reduction in phagocytic activity. 
However, further studies are needed to confirm the MPO activity reduction.  
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Excretion studies demonstrated that most of the administered MON was rapidly 
excreted (within 6 h) into urine, which was expected, as MON is a small hydrophilic 
molecule. Only traces could be detected in feces, suggesting effective absorption 
from the gut. However, only 42% of the dosed MON was detected in urine. The 
rest was probably metabolized  or degraded and re-cycled, knowing that MON is 
synthetized from two acetate-CoA units by oxidation and dehydration reactions 
(Franck and Breipohl, 1984, Miller and Trenholm, 1994). The ring structure of 
MON may open and degrade to CO2 (exhaled) and acetate.
Even though MON was found to be quite toxic in vivo, the in vitro findings 
were contradictory. MON did not induce toxic effects on the studied endpoints, 
cell membrane integrity or ATP production, and only very high concentrations 
(ED50 = 800 µM) reduced cell proliferation. However, toxicity of very high doses 
(> 2000 µM) cannot be excluded.  One explanation could be that MON, being a 
hydrophilic compound, could not effectively enter the cell through the lipid bilayer 
of the cell membrane, but rather gained access into the body between cells. Gap 
junctions allow direct connections between the cytoplasms of two adjacent cells. 
Gap junction proteins, connexins, from adjacent cells form a hydrophilic channel 
between them, allowing ions and small molecules such as cyclic AMP (MW= 329 g/
mol) and cGMP to pass from cell to cell (Kanaporis, et al.,2008). Gap junctions are 
especially important in cardiac muscles, being partly responsible for the co-ordinated 
heart beat (Smyth and Shaw, 2012, Juncueira, 2016). The molecular weight of MON 
is low enough to access connexons (90 g/mol) and perhaps it could somehow use 
gap junctions or other hydrophilic channels or receptors to enter cells, especially 
cardiac cells. In cell cultures, the cell density is lower and MON might not efficiently 
enter the cells and hence not be toxic. It is, however, clear that MON does enter the 
body quite effectively via the oral route and seem to affect the cardiac muscle cells 
most. Biotransformation reactions of MON are still unclear, hence, toxicity due to 
reactive metabolites cannot be ruled out. 
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7. CONCLUSIONS
EnnB exposure of cell lines Balb 3T3 and HepG2 induced cytotoxic effects in the 
form of altered cell proliferation and reduced ATP levels, at low concentrations 
(below 10µM). Concurrently, a slight increase in the proportion of early apoptotic 
cells could be seen in the cell line Balb 3T3. At the concentrations studied, most 
of the cells, however, survived and normal cell morphology was maintained. The 
toxic response to EnnB in rat primary hepatocytes was quite different, indicating 
necrosis rather than apoptosis. Gene expression studies in rat primary hepatocytes 
suggested an alteration of cell energy metabolism via effects on the function and 
assembly of complex I of the mitochondrial electron transfer chain (ETC). We 
propose that EnnB acts by causing energy deprivation due to alteration of the 
mitochondrial ETC, leading to a decrease in cell proliferation of cell lines and 
necrotic cell death in primary cells. This highlights the importance of recognizing 
the differences between cell lines, primary cells, organ slices and animals, especially 
when assessing the in vivo relevance of in vitro findings.
The outcome of the acute and subacute oral toxicity study on rats was that 
MON is acutely toxic to rats, with high doses inducing respiratory distress and 
severe cardiovascular changes, resulting in death. According to the OECD Globally 
Harmonized System, the toxicity of MON could be classified into category 2, with 
an LD50 cut-off value of 25 mg/ kg b.w. However, even doses between 10-25 mg/
kg b.w. caused severe toxicity. Subacute exposure to lower levels of MON (≤ 9 mg 
/ kg b.w.) did not induce clinical signs. However, MON altered innate immunity 
by reducing the phagocytic activity of neutrophils, which already occurred at low 
exposure levels (≤3 mg/kg b.w.). Hence, we suggested a LOAEL of 3 mg/kg b.w. for 
MON. MON was rapidly excreted into urine (in 6-24 h) and being a polar substrate 
was unlikely to accumulate in the body. In contradiction to in vivo studies, MON 
did not induce toxicity in vitro in the cell lines Balb 3T3 and HepG2 at tested, 
rather high concentration levels. As in vivo toxicity mainly were due to cardiac 
changes, further studies on mechanism of toxicity, using a cardiac myocyte model 
would be well-grounded.
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